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This thesis discusses the fabrication of magnetic metal oxide (Fe3O4, Gd2O3) 
nanoparticles for theranostic applications, viz, Fe3O4 nanoparticles for cancer 
therapy as in magnetic hyperthermia and Fe3O4, Gd2O3 nanoparticles for 
diagnostic applications as in magnetic resonance imaging (MRI). The other 
applications of magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles are beyond 
the scope of this thesis. This thesis also discusses the influence of 
physiological components like proteins and ions under the applied alternating 
current magnetic field, on the efficiency of magnetic hyperthermia.  
 
1) Hydrophilic Fe3O4 nanoparticles of different size, shape, composition and 
surface modification were fabricated. Among the 10 nm 
superparamagnetic iron oxide nanoparticles (SPIONs) and 30 nm 
ferrimagnetic iron oxide nanoparticles (FIONs), FIONs have higher 
magnetic saturation and hence show higher SAR value irrespective of the 
surface modifying agent used. Different surface modifying agents were 
used to convert the as-synthesized oleic acid capped, hydrophobic Fe3O4 
nanoparticles to hydrophilic phase. Among the surface modifying agents 
used, (3-Aminopropyl) trimethoxysilane (APTMS) capping showed better 
stability when compared to Cetyl Trimethyl Ammonium Bromide (CTAB) 
or Polyethyleneimine (PEI) coating. Hence APTMS was further used in 
our hydrophilic phase transfer experiments. Both 10 nm and 30 nm Fe3O4 
nanoparticles show very high cell viability. We had fabricated hydrophilic 
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nanospheres, nanohexagons and nanotetragons of 20 nm size. 
Nanotetragons were found to show polydispersity and also exhibited high 
magnetic hyperthermia efficiency. Composition of the Fe3O4 nanoparticles 
were modified by doping with divalent ions like cobalt and nickel. 
CoFe2O4 nanoparticles of size 15 nm show higher coercivity and hence 
higher SAR value when compared to 15 nm Fe3O4 nanoparticles and 150 
nm NiFe2O4 nanoparticles. Discussion about the manipulation of size, 
shape and composition of Fe3O4 nanoparticles gives preliminary insights 
into use of Fe3O4 nanoparticles for magnetic hyperthermia applications. 
Hydrophilic phase transfer improves the colloidal stability of magnetic 
metal oxide (Fe3O4, Gd2O3) nanoparticles in de-ionised water. But 
improving the biocompatibility enhances the potential chance of the 
magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles for biomedical 
applications. Therefore we have discussed the fabrication of albumin 
conjugated 30 nm Fe3O4 nanoparticles. Fe3O4 nanoparticles of size 30 nm 
were chosen as the core magnetic material, for better magnetic properties, 
as discussed earlier. Bovine Serum Albumin (BSA) conjugation has found 
to enhance both the biocompatibility and the heating efficiency of the 
Fe3O4 nanoparticles. We have conjugated BSA over surface modified 
Fe3O4 nanoparticles by physical adsorption method using CTAB and 
covalent amide bond formation by APTMS. Albumin is the most abundant 
protein present in blood plasma and hence it offers better stealth 
characteristics. This is proved by haemolytic studies and cell viability 
studies using BHK cell lines for BSA conjugated 30 nm Fe3O4 
nanoparticles. BSA conjugation also renders better stability and prevents 
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aggregation of Fe3O4 nanoparticles in water, thus enhancing the heating 
efficiency of 30 nm Fe3O4 nanoparticles. Thus we have proposed a single 
combinatorial approach for improved biocompatibility and enhanced 
magnetic hyperthermia performance. 
 
2) Various physical and chemical parameters like size, shape, anisotropy, 
composition, applied magnetic field etc., influence the magnetic 
hyperthermia efficiency of magnetic nanoparticles. It is plausible that the 
physiology of any biosystem will also impact the efficiency of magnetic 
hyperthermia system since the odyssey of the injected magnetic 
nanoparticles involves passage through blood to tumor site. Thus we have 
attempted to explore the basic properties of Fe3O4 nanoparticles once 
inside a biosytem. Physiological components like ions and proteins have 
found to influence the performance of 10 nm Fe3O4 nanoparticles inside 
biosystem. While physiological ions enhance the heating efficiency of 10 
nm Fe3O4 nanoparticles due to their motility, the physiological proteins 
and cells present in blood plasma, restrict the mobility of the ions, thereby 
retarding the heating efficiency of the 10 nm Fe3O4 nanoparticles. Thus 
acting as biosafety agents. Therefore the adverse effects of magnetic 
nanoparticles on a biosystem is under check. We have also found that AC 
magnetic field at therapeutic range does not cause damage to the tissue, 
thus confirming that magnetic hyperthermia effect is brought about by 10 
nm Fe3O4 nanoparticles under the influence AC magnetic field. This study 





3) Gd2O3 nanoparticles with various surface modifications to enhance the 
relaxivity and biocompatibility of the same were fabricated. Organic 
protein (albumin) conjugated Gd2O3 nanoparticles with very good 
biocompatibility and relaxivity were fabricated. We have also fabricated 
inorganic, in-situ photodegraded, short chain polyvinyl pyrrolidone (PVP) 
coated Gd2O3 nanoparticles. PVP coated Gd2O3 nanoparticles show 
excellent relaxivity in water and comparable biocompatibility with BSA 
conjugated Gd2O3 nanoparticles. 
 
 
4) We have fabricated iron oxide-gadolinium oxide (Io-Go) nanoclusters 
which can be used as a multifunctional platform for cancer theranostics in 
magnetic hyperthermia for cancer therapy and dual mode MR image 
contrast agents. This gives the nanoclusters a theranostic potential. The 
Polydopamine (PDA) coated Io-Go nanoclusters show effective magnetic 
hyperthermia efficiency without compromising on the cell viability. It also 
shows significant tumor necrosis. Thus, making it a very good magnetic 
hyperthermia agent. The PDA coated Io-Go nanoclusters are also found to 
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Magnetism is the phenomenon by which some materials attract or repel other 
materials from a distance. Magnetic materials include iron, lodestone and 
some steels. Generally, magnetic forces are generated by moving charged 
particles which generate magnetic field [1]. When a magnetic material is 
placed in an external magnetic field, the atoms in the material possess an 
atomic moment.  Magnetic dipoles exist in magnetic materials which can 
respond to the external magnetic field. Magnetic induction is given by the 
equation 1.1, 
B = μ0 (H + M)            (1.1) 
where μ0 is the permeability of free space (its magnitude is 1.257 × 10−6 
H/m); M is the magnetic moment m per unit volume of the material; H is 
magnetic field strength. Magnetic susceptibility is given by the equation 1.2, 
M= χH                    (1.2) 
The magnetic response to external magnetic field results in materials being 
classified as diamagnetic, paramagnetic or ferromagnetic. Diamagnetism is 
when the response to external magnetic field is very weak and not permanent; 
it is due to the change in the orbital motion of electrons due to the external 
field, the direction of the induced magnetic moment is opposite to the field. In 
paramagnetism, because of incomplete cancellation of its electron magnetic 




moments, each atom has a permanent dipole moment. When an external field 
is applied, the atomic dipoles align with the field. Diamagnetic and 
paramagnetic materials exhibit magnetization in the presence of an external 
field; They have low susceptibility implying that their magnetic induction is 
very weak. Ferromagnetism occurs, for example, in body centred cubic (b.c.c.) 
iron, cobalt, nickel, and in many alloy compositions based on Fe, Co and Ni. 
Ferromagnetic materials show permanent magnetic moments even in the 
absence of an external field. They have high susceptibility values up to 106. 
The magnetic moments in such materials arise from atomic spin magnetic 
moments [2]. Fig. 1.1 gives a schematic overview of different categories of 
magnetic materials. 
 
Fig. 1.1: Schematic overview of B as a function of H for various materials [1]. 





Based on B-H loop magnetic materials can be classified soft and hard 
magnetic materials. For hard magnetic materials, the area under the B-H loop 
is much larger than that of soft magnetic material with a large coercivity. 
Examples of magnetically soft materials are commercial iron ingot, oriented 
silicon-iron and Ferroxcube A (48% MnFe2O4 –52% ZnFe2O4) and that of 
hard are Cunife (60% Cu-20% Ni-20% Fe), sintered ferrite 3 (BaO-6 Fe2O3) 
[3]. 
 
Applications of magnetic materials 
 
Magnetic materials find a myriad of applications in information storage, 
biomedicine [4] and magnetic energy storage [5]. Permanent magnets supply 
larger magnetic energy in even smaller volumes to be used in applications like 
transportation components, consumer products, clean energy technologies, 
military hardware and hybrid vehicle regenerative motors. Rare-earth 
“supermagnets,” made of iron, cobalt, and rare-earth elements such as 
Neodymiium, Samarium etc., have accounted for the majority of high-energy 
product permanent magnets for hi-tech applications [6-8].Magnetic materials 
are also used to improve the magnetic storage capacity of devices like 
magnetic tapes, and computer hard discs etc., [9]. Soft magnetic material 
widely used in motors, compressors and other rotating devices [10]. For 
inductor applications, powder magnetic material cores which give ease in 
manipulation of shape, size, winding etc., are being popularly used [11]. 
Magnetic nanoparticles form a very important class of magnetic materials. 




Owing to their finite size, they have a high surface-to-volume ratio and 
different crystal structures. This gives magnetic nanoparticles their interesting 
magnetic properties when compared to their bulk counterparts [12]. Magnetic 
nanoparticles are used as giant magneto-resistance (GMR) sensors, Spintronic 
sensors, Spin Dependent Tunneling (SDT) sensors, etc., inorder to detect and 
quantify labels [13]. Integrated magnetic/spintronic device microarrays have 
also shown to have a great potential in both biomedical research and practices 
[14]. Magnetic nanoparticles find their major application as contrast agents for 
imaging, cell separation, site-specific drug delivery agents, cancer 
therapeutics, water treatment etc., [15-17].  
 
1.2 Biomedical applications of magnetic materials 
 
This section focuses in-depth about the biomedical applications, as they are 
the prime focus of this thesis. The common biomedical applications of various 
magnetic materials especially magnetic metal oxide (Fe3O4, Gd2O3) 
nanoparticles giving more emphasis on cancer theranostics is discussed. 
Though magnetic hyperthermia and magnetic resonance imaging (MRI) are 
discussed in this section, they are described more detailed in the subsequent 
sections. The earliest known biomedical use of naturally occurring magnetic 
materials is the use of magnetite (Fe3O4) or lodestone by the Indian surgeon 
Sushrutha around 2,600 years ago. Current areas in medicine to which 
magnetite can be used include molecular and cell biology, cardiology, 
neurosurgery, oncology and radiology. Magnetic nanoparticles for biomedical 
applications should meet special criteria with respect to size, dispersity, 




surface charge, biodegradability and specificity. To meet out these criteria, 
many pathways have been developed to synthesize magnetic nanoparticles and 
manipulate their functionalities through surface functionalization, coating and 
encapsulation strategies [18, 19].  Fig. 1.2 gives a overview of the various 
biomedical applications of magnetic nanomaterials. 
 
 











Magnetic Separation  
 
Magnetic particles can be used to separate entities from their surroundings so 
as to purify or concentrate the surrounding entities [20]. This application is 
based on the difference in the susceptibility between the magnetically labelled 
entity and the surrounding medium. Examples of the use of this principle are 
magnetic cell sorting for cellular therapy and immunoassay. The first step is to 
label the entities like bacteria or cellular vesicles with the particles followed 
by the separation of the labelled entities by magnetic separation.  
 
Drug and Gene Delivery  
 
Most chemotherapy methods are relatively non-specific and hence are 
“wasted” by being distributed to areas where they are not required, leading to 
undesirable side effects. Drug delivery vehicles can carry the drugs to the 
target site and can also be fine-tuned to control the release of the drug. Much 
of the work which has been performed so far relates to targeting cancerous 
tumors. The optimum size of drug delivery vehicles is 5–100 nm size range. 
Typically, magnetite particle, or noble metals such as gold and silver is used 
for this application. Surface modified magnetic particles can be further 
manipulated and functionalized by attaching moieties like carboxyl groups, 
biotin, etc.  [21, 22] which serve to couple various therapeutic drugs or target 
antibodies to the surface modified magnetic particles complex. Later these 
magnetic carriers are used to target specific sites or organs in the body for 
tumour therapy or gene  





delivery [23, 24]. Radionuclides (e.g., β–emitters, β is the symbol used to 
denote an electron) can also be attached to the magnetic particles to be used as 
targeting agents. Since the radionuclide does not have to be released in the 
same way as the drug, control drug release is absent [25]. This technique is 
also called magnetofection, as it involves the use of magnetic particles to 
increase the efficiency of gene transfection (introduction of foreign DNA into 
a host cell) and expression [26]. The gene is carried inside a viral vector 
coated on the surface of the magnetic particle. This particle can then be held at 
the target area by applying a magnetic field. The virus is thus in contact with 
the tissue for increased duration which improves the transfection efficiency. 
 
 
Artificial Muscle  
 
Hydrogels, which are cross-linked polymer networks swollen with water, can 
be used to make soft actuators. Since most gels are relatively homogenous 
materials which shrink or swell uniformly, there is a need to improve the 
response of gels. Hence, magnetic field sensitive gels where magnetic particles 
of colloidal size are dispersed and incorporated into the gels are developed. 
These ferrogels combine the magnetic properties of magnetic fillers and the 
elastic properties of hydrogel. Iron oxide particles fused Polyvinyl alcohol 
(PVA) gel has been used for this application because of its mechanical  
 
 







The idea that a localized raise in temperature of upto 42-45◦C can be used to 
selectively destroy malignant tumor cells by magnetic particles which can be 
heated by an applied alternating current magnetic field.  
 
Image Contrast Agents 
 
So far, we have only considered magnetic properties associated with the 
electrons in the material. However, protons also have a magnetic moment, and 





The motivation of our thesis is primarily focused on magnetic materials for 
cancer theranostics. Iron oxide nanoparticle-based cancer therapy represents 
an important alternative to conventional chemotherapy, radiation, or surgery. 
Iron oxide (Fe3O4) nanoparticles are composed of 3 integral parts- iron core, a 
polymer coating, and functional moieties [28].In spite of the extensive 
researches in nanomedicine, there are still unmet medical demands in cancer 
diagnosis and therapy. Advanced multimodal imaging facilitates the early 
stage diagnosis and real-time monitoring of diseases, especially cancer [29]. 
Nanomedicine for cancer treatment however, will have the greatest impact on 




society when administered in combination with traditional therapies. 
Combination chemotherapy is a primary cancer treatment regimen to reduce 
cancer drug resistance [30]. Cancer theranostic approaches in pancreatic and 
brain cancers, increase the use of magnetic nanoparticles due to difficulty in 
positioning the tumor near sensitive organs, delivering treatment to the 
targeted organs and also extensive adverse reactions to conventional 
treatments techniques [31].  
 
1.3 Magnetic Hyperthermia 
 
Magnetic hyperthermia uses magnetic nanoparticles as heat sources [32] to 
raise the tissue temperature to ~42-46 °C. At this temperature,  tumour cells 
are known to be more sensitive to heat than healthy cells [33]. Magnetic 
hyperthermia has synergistic effects when combined with other conventional 
treatment strategies like chemotherapy or radiotherapy. Low oxygen and 
nutrients concentration coupled with low pH make tumor cells more heat 
sensitive. Extensive research has been done to fabricate magnetic 
nanomaterials used for magnetic hyperthermia, manipulate the alternating 
current magnetic field strengths, alternating field frequencies and exposure 
times, etc., [34].The successful clinicaltrials demonstrated the feasibility of 
this technique.Among the first clinical studies of magnetic hyperthermia is the 
treatment of brain tumours like glioblastoma multiforme through a 
combination of radiotherapy and magnetic hypethermia. Here, magnetic 
resonance imaging was used in choosing the injection site and CT imaging 
was used in the follow up [35]. More complete evaluation of the clinical 




outcomes is to be assessed with a larger group of patients and with different 
types of cancer [36, 37]. The prospect of combining magnetic hyperthermia 
with drug delivery is also next potential step in this field. Fig. 1.3 gives an 
overview of magnetic hyperthermia strategy. 
 
Fig. 1.3: Schematic representation of magnetic hyperthermia. Magnetic 
nanoparticles accumulate in tumors, targeting the cancer cells. When exposed 
to an alternating magnetic field, the nanoparticles tend to align with the 
applied field absorbing energy. MNPs oscillation transform this 
electromagnetic energy into heat, increasing the temperature at this region[28] 
 
Basel et al. have synthesized superparamagnetic iron/iron oxide nanoparticles 
and injected the same into RAW264.7 cells (mouse monocyte/macrophage-
like cells). It was observed from the results that these nanoparticles selectively 
infiltrate pancreatic tumors when injected intraperitoneally without affecting 
healthy tissue [38]. Huang et al used magnetic nanoparticle in a subcutaneous 
squamous cell carcinoma mouse model. At a well-tolerated intravenous dose 
of 1.9 mg Fe/g tumor and application of an external magnetic field, tumors 
were heated to 60 ◦C in 2 min suffering ablation [39]. Peptide coated magnetic 
nanoparticles like aminosilane coated iron oxide nanoparticles was reported by 
Tsiapa et al [40]A high specificity, targeting glioblastoma tumors was 
observed.  





All these reports throw a positive light on the potential application of suggest 
that this hyperthermia system using magnetic nanoparticles can cause tumor 
specific heating  
 
Iron Oxide (Fe3O4) Nanoparticles   
 
In recent years magnetic metal oxide nanoparticles have attracted considerable 
attention due to the ease and rapid progress in fabrication and processing. 
Among them, Fe3O4 nanoparticles are widely used in magnetic hyperthermia 
applications. Their magnetic properties are highly influenced by the variations 
in size, shape, composition and surface modification [41, 42]. Domain 
evolution is a very important criterion with regards to size and shape. Below a 
critical size, the Fe3O4 nanoparticles become single domain. Decrease in the 
size below 10 nm results in superparamagnetism with exciting magnetic 
properties.  Fe3O4 nanoparticles of size 30-50 nm have higher magnetic 
saturation and are ferrimagnetic in nature [43, 44]. Similarly, shape also plays 
an important role in the determination of domain structure. Inorder to 
minimize energy, different shapes have distinct magnetic domain structures, 
which leads to significant change in both static and dynamic magnetic 
behaviors. Thus Fe3O4 nanoparticles of different shapes and sizes are find a 
plethora of applications especially in biomedicine [45, 46]. Increasing the 
magnetic anisotropy by partially replacing the ferrous ions by more 
anisotropic divalent ions like cobalt and nickel enhances the magnetic 
properties of the Fe3O4 nanoparticles, even at superparamagnetic size regime 




[47, 48]. To further improve the biological application, Fe3O4 nanoparticles 
have to be made hydrophilic and biocompatible. Therefore, the surface 
modified size, shape, composition dependent magnetic properties of Fe3O4 
nanoparticles are of great interest in biomedical field.  
 
As mentioned earlier, the size, shape and composition are crucial for both the 
static and dynamic behaviors of Fe3O4 nanoparticles. Fig. 1.4 illustrates the 
evolution of magnetic domain and size dependent coercity (Hc). As shown in 
the figure, when the particles size is above single domain critical size (Dc), 
multi-domain (MD) prevails. 
 
 
Fig. 1.4: Magnetic coercivity (Hc) vs. particles size [49]. 
 




Because of the small size of super paramagnetic iron oxide nanoparticles, 
large fractions of the total atoms in a super paramagnetic iron oxide 
nanoparticles are surface atoms [50]. As the particle size decreases, coercivity 
increases and reaches a maximum at Dc, thus aligning all the spins in 
nanoparticles parallel. Further decrease in particle size results in drop of the Hc 
due to superparamagnetism phenomenon. This phenomenon prevails when the 
measurement time is much larger that the Neel relaxation time given by 
equation 1.3, 
                         (1.3) 
 
where, - a relaxation time (~10-9 s);  - Boltzmann constant; T-
temperature;   K-the anisotropy constant; V-volume of nanoparticle, 
respectively.  
 
It can be seen from the equation that  decreases with the decreasing size. 
Superparamagnetism is the unique property of ultrasmall magnetic metal 
oxide nanoparticles. It is extremely useful for biomedical application. The size 
of superparamagnetic metal oxide nanoparticle is so small that agglomeration 
due to gravitation forces can be avoided [51] and also the weak interaction is 
advantageous for the stability of the magnetic fluid [52, 53]. Due these 
advantages, superparamagnetic nanoparticle are commonly employed for the 
ferrofluids and biomedical applications. Superparamagnetic metal oxide 
nanoparticles suffer from surface effect due to high surface to volume ratio, 
resulting in decrease of Ms because of serious surface spin disorder [54].  So  




far, there are many reasons responsible for the spin disorder at the surface of 
magnetic metal oxide nanoparticles. One of the reasons is the broken exchange 
bonds between surface spins and reduced coordination, as shown in Fig. 1.5.  
 
 
Fig. 1.5: A 2.5 nm particle showing surface spin disorder [55]. 
 
The effective anisotropy (Keff) of a spherical nanoparticle is the sum of the 
surface anisotropy (Kv) and volume anisotropy (Ks), given by the equation 1.4, 
 
Keff = Kv +6 Ks /d                               (1.4) 
 
where, d-the diameter of the particles [56]. The contribution of surface 
anisotropy is negligible for large particles. 
 




Our thesis also discusses the use of ferrimagnetic Fe3O4 nanoparticles for 
enhanced heating efficiency for magnetic hyperthermia. Ferrimagnetic Fe3O4 
nanoparticles have different atoms residing on different lattice sites with 
antiparallel magnetic moments but still their magnetic moments do not cancel 
out as they are of different magnitudes resulting in a net spontaneous magnetic 
moment. Despite wide research on the magnetic properties of these 
ferrimagnetic Fe3O4 nanoparticles, their magnetic behavior is not well 
established [57-59]. Studies suggest the occurrence of surface structure defects 
on ferrimagnetic Fe3O4 nanoparticles leading to magnetic disorder extending 
into the core of a given thickness.  As discussed by  Kodama et al, the 
exchange coupling between the core and surface gives rise to a variety of spin 
distributions within the ferrimagnetic Fe3O4 nanoparticles [60, 61]. 
 
Magnetic hyperthermia Mechanism 
 
Relaxation loss and hysteresis loss, are the two main mechanisms responsible 
for the heat dissipation of superparamagnetic Fe3O4 nanoparticles subjected to 
the applied alternating current magnetic field. The Brownian relaxation is the 
rotation of nanoparticle due to the torque under applied alternating current 
magnetic field, while the Neel relaxation is the rotation of magnetic moment, 
while the nanoparticle is stationary as illustrated in Fig. 1.6. 
 
 





Fig. 1.6: Illustration of Néel and Brownian relaxation of magnetic 
nanoparticles exposed in external magnetic field [62]. 
 
The Néel and Brownian magnetic relaxation times of a particle are given by 
thefollowing equations 1.5, 1.6, 1.7, 
/KT                                      (1.5) 
/KBT                          (1.6) 
                                (1.7) 
Where,  is the Néel relaxation time;  is the Brown relaxation time; τ is 
the effective relaxation time;  is about 10-9 s; K is the magnetic anisotropy 
constant; Vh is the Hydrodynamic volume of nanoparticle (the volume of a 
hypothetical hard sphere that diffuses in the same fashion as that of the 
particle  





being measured);  is the nanoparticle volume, KB is the Boltzmann 
constant; T is the temperature, is the viscosity of the base liquid (water 8.94 x 
10-4 Pas). Specific absorption rate (SAR) estimates the heating performance of 
the thermal seed given by the equation 1.8,  
 
SAR= P/ρφ       (1.8) 
 
It should be noted that the Brownian-Néel relaxation loss is the main resource 
of heat generation in the superparamagnetic regime. When the size of 
magnetic nanoparticle is increased into the ferrimagnetic or ferromagnetic 
regime, hysteresis loss dominates relaxation loss. The hysteresis loss 
originates from the hysteresis behavior of ferrimagnetic or ferromagnetic 
magnetic magnetic Fe3O4 nanoparticles when exposed to a time varying 
magnetic field. The amount of heat generated per volume is given by equation 
1.9, 
P= µ0 f∫HdM            (1.9) 
 
The calculation of the hysteresis loss is more complicated when compared to 
the relaxation loss. Different methods are applicable in different particle size 
regimes. For instance, a linear response theory is valid for the 
superparamagnetic Fe3O4 nanoparticles [63]. Whereas for the coherent 
rotation of ferri or ferromagnetic Fe3O4 nanoparticles, the Stoner–Wohlfarth 
model based theories are applicable [64]. Also numerical methods were also 
developed to calculate the hysteresis loss for the single domain nanoparticles 




[65]. However, the theoretical methods mentioned are suitable only for the 
single domain particles.  After knowing the mechanisms of magnetic 
hyperthermia, a lot of work has been devoted for optimization of the heating 
seed to achieve the maximum heat dissipation ability/ SAR value.  
 
Generally, the optimization was mainly focused on three aspects, namely size, 
shapes, compositions and surface modification to prevent agglomeration. 
Hergt proposed that maximum heat generation is expected by Fe3O4 particle 
suspensions with narrow size distribution with a mean diameter corresponding 
to the maximum coercivity in the single domain [66]. The sizes under study 
are 10 nm superparamagnetic Fe3O4 nanoparticles and 30 nm Fe3O4 
nanoparticles. Vallejo-Fernandez et al. pointed out that a slight change in 
shape distribution would result in significant change in hysteresis loss for the 
hyperthermia system where the shape anisotropy dominates [67]. Ma et al. 
reported that the magnetite nanoplates exhibited high SAR values [68]. Cubic 
nanoparticles are demonstrated to exhibit higher power absorption values than 
the spherical [69].  Different shapes with varying anisotropy like, nanospheres, 
nanocubes, nanotetragons, nanohexagons, nanooctahedron etc., were 
synthesized. Since composition also determines the Ms and K values, which 
influence the hyperthermia performance, CoFe2O4 and NiFe2O4 nanoparticles 
with high magnetization superior to the ferrite were intensively studied as 
heating seeds for hyperthermia [70, 71]. Preventing agglomeration also 
significantly increases the SAR value, thus different surface modifying 
strategies are also discussed in this thesis [72]. Surface modification also 
render hydrophilicity and biocompatibility [73]. It can be known from above 




discussions that magnetic hyperthermia is very sensitive to parameters of the 
heating seed, such as size and size distribution, shape and shape distribution, 
and composition and surface modification.  
 
Just as any treatment strategy influences and affects the bio-system, the bio-
system also unequivocally affects the efficiency of the treatment strategy. Our 
paper attempts to study the influence of biological system over the heating 
efficiency of a good magnetic hyperthermia system. Blood is the first and 
foremost influential biological parameter that would possibly influence the 
heating efficiency since Fe3O4 nanoparticles are injected into the blood stream. 
Blood flow plays a significant role in determining the heat dissipation in 
normal and tumor vasculature. The total volume of blood flowing in a tumor 
region is limited when compared to that in normal region. Therefore the heat 
dissipated by blood flow in tumor site is slower, which implies that the 
temperature raise in the tumor region is actually higher [74, 75]. Though it 
might seem to be a positive factor for magnetic hyperthermia system, it is 
actually not achieved everytime as the relative perfusion of blood in tumor site 
remains greater than that in the healthy tissue [76, 77]. Thermotolerance is an 
unavoidable side effect of any hyperthermia therapy as a resistance to heat is 
subsequently developed by the tumor cells [78, 79]. This could be seen as a 
factor that would influence the efficiency of the magnetic hyperthermia 
system. Surpassing all this, the odyssey of the injected Fe3O4 nanoparticles 
into the blood stream towards the tumor site, places a very important role. The 
injected Fe3O4 nanoparticles are dispersed into the blood stream and only a 




tiny fraction of the same reaches the actual tumor site, of which an even lesser 
fraction diffuses into the tumor cells [80, 81].  
 
The irregular angiogenesis in the tumor site also further mitigates the destiny 
of the Fe3O4 nanoparticles into the tumor region [82]. Thus if the Fe3O4 
nanoparticles should have to encounter so many obstacles before reaching the 
targeted tumor site, the efficiency of a Fe3O4 nanoparticles based magnetic 
hyperthermia system is definitely subjected to a plethora of factors that tend to 
influence the results obtained in a lab. 
 
1.4 Magnetic Resonance Imaging 
 
Magnetic metal oxide nanoparticle made of the elements iron (Fe), gadolinium 
(Gd) or manganese (Mn) are widely used in many diagnostic applications 
performed under magnetic resonance imaging (MRI). MRI scanners 
reconstruct images from the electromagnetic signals generated by the 
stimulation, and relaxation, of the large pool of hydrogen (1H) protons found 
in biological tissues. By atomic and molecular level interactions, magnetic 
metal oxide (Fe3O4, Gd2O3) nanoparticles influence the relaxation time of 
hydrogen protons contained in small molecules like water. Thereby, magnetic 
metal oxide (Fe3O4, Gd2O3) nanoparticles induce contrast enhancement effects 
on the reconstructed MR images. MRI is the most reliable, high resolution (75 
– 300 µs), and multifunction imaging modalities of modern medicine. It 
allows the acquisition of in-depth, whole-body images, from the mouse model 




to the humans when compared to optical imaging and echography. Unlike 
compute tomography  
 
(CT), it does not rely on ionizing radiation. Moreover MRI also enables the 
tracking of cells, molecules, and drug delivery vehicles inside the biosystem.  
MRI has a relatively poor sensitivity compared to the other techniques. To 
fully exploit the potency of MRI in molecular and cellular imaging 
applications, it is necessary to design contrast agents which have the capacity 
to very efficiently interact with hydrogen protons.  Most clinically approved 
contrast agents are based on small molecules that sequestrate the paramagnetic 
Gd3+ [83, 84]. Gadolinium has 7 unpaired electrons in the 4f orbital giving it a 
very large magnetic moment, a relatively slow electronic relaxation rate and 
enhanced proton relaxation properties [85]. Fe3O4 nanoparticles can also be 
used as MRI contrast agents. The strength of the magnetic field in common 
MRI scanners range from 1 to 3 Tesla. When a patient is introduced in the 
gantry of MRI machine, 1H in the body align their spins along the direction of 
the magnetic field (B0), as shown in Fig. 1.7 (a). The sum the magnetic 
moments of these spins represent the “macroscopic magnetization vector” of 
biological tissue. This vector orients along the main magnetic field of the 
scanner. In their initial state, the spins “precess” at a certain frequency called 
Larmor frequency and are not coherent in phase. Later a radiofrequency (RF) 
wave tuned at Larmor conditions using a transmitter coil, is applied to the 
biological tissue. This causes the excitation of 1H spins causing spins lose their 
preferential orientation along the main magnetic field (Fig. 1.7 (b)).  At this 
moment, the oscillation motion along the x-y plane is detected by a receiver 




coil and is recorded. This represents the “MRI signal”. Then, the “x-y” phase 
coherence (Mxy) is gradually lost as neighboring 1H protons exert a mutual 
influence on each other  
 
as shown in Fig. 1.7 (c). As shown in Fig. 1.7(d), the time constant that 
quantifies this loss of phase coherence is the transversal relaxation time (T2). 
As shown in Fig. 1.7(c), the excited spins gradually release their energy and 
recover their initial orientation along the main magnetic field of the scanner 
(Mz recovery). This return to the initial macroscopic magnetization state 
occurs within longitudinal relaxation time, T1 as represented by Fig. 1.7(d). It 
is to be noted that T1 and T2 are intrinsic properties of any biological tissue.  
 
 
Fig. 1.7: Schematic overview of the macroscopic magnetization vector 
generated by magnetic resonance excitation [85]. 
 
 




The signal recorded for a given tissue (S), using a basic spin-echo sequence, is 
given by equation 1.10, 
S = ρ(1− e (−TR/T1 ) )(e −TE/T2 )       (1.10) 
Where, TR and TE are the repetition and the echo times (parameters in the 
spin-echo sequence [86]. The impact of contrast agents on the relaxation rate 
of protons, measured in constant conditions of magnetic strength and 
temperature, is given by the equation 1.11, 
Ri=1/Ti=1/Ti0+riC             (1.11) 
where Ri =1,2 is the relaxation rate of the aqueous solution, Ti0 is the 
relaxation time of the aqueous media in the absence of the contrast agents, 
ri=1,2 is the relaxivity (usually at T = 20 or 37o C, pH = 7, and B0 = 1.5 or 3.0 
Tesla), and C is the contrast agents concentration (in mM of Gd, Fe, or Mn). 
The relaxometric performance of MRI contrast agents is assessed by 
measuring their relaxation rates (1/T1 and 1/T2). Though magnetic metal oxide 
(Fe3O4, Gd2O3) nanoparticles have other applications, we have tried to focus 
only on the theranostic application of the same. Thus, the scope of this thesis 
limits to therapeutic application as in magnetic hyperthermia and diagnostic 









Gadolinium oxide (Gd2O3) nanoparticles  
 
Gadolinium oxide (Gd2O3) nanoparticles are primarily used as MRI contrast 
agents. Gd3+ has seven unpaired electrons whose spin perturbs the proton 
relaxation in water resulting in an efficient shortening of longitudinal 
relaxation time (T1) and increase the magnetic resonance signal intensity. 
They are the most commonly used contrast agents in MRI, especially for fine 
vasculature in MR angiography and brain tumor enhancement [87]. Gd(III) 
chelates are popular for no other ion has seven unpaired electrons. BInorganic 
crystalline gadolinium based compound nanoparticles provide a rigid crystal 
environment that effectively prevents the release of free Gd3+and hence are 
considered as a new generation of T1 contrast agents [88, 89].A polymer 
coated Gd(III) chelate will stay in the blood to allow for thorough MRI 
examinations. It can then be degraded and cleared from the body(90).Though 
the advantages of Gd chelates seem to be evident, the obvious disadvantage is 
that, the surface atoms are not exposed.It is widely accepted that only the 
gadoliniumon the surface contributes to the contrast effect. Hence, the 
preparation of monodispersed ultra-small nanoparticles with uniform size and 
large surface area is very important. Several methods have been developed to 
synthesize small sized Gd2O3 nanoparticles for the application in MRI contrast 
agents. Preparation from gadolinium precursors in the presence of stabilizers 
such as polyethylene glycol or its derivatives results in stable Gd2O3 colloidal 
solutions with particle size ranging from 2 to 15 nm [91, 92].   
 
 




1.5 Research Motivation 
 
1) Magnetic hyperthermia is a non-invasive and non-toxic cancer treatment 
strategy. The existing cancer treatment strategies like surgery, radiotherapy 
and chemotherapy have considerable side effects like damaging the 
healthy tissue, often without success in case of metastatic cancer. In this 
juncture, magnetic hyperthermia poses very important advantages over the 
traditional ones- (i) the small particle size allows the magnetic 
nanoparticles to pass through the biological barrier (ii) injection of 
magnetic nanoparticles for magnetic hyperthermia is less invasive; (iii) 
Magnetic nanoparticles can be manipulated to target the tumor site, thus 
enhancing specificity; (iv) magnetic nanoparticles used for hyperthermia 
can be also used as a diagnostic agent for MRI. Therefore magnetic 
hyperthermia treatment strategy forms the prime motivation of this thesis. 
 
2) As discussed earlier, the magnetic hyperthermia properties Fe3O4 
nanoparticles are of prime interest of this thesis, due to the effect of size, 
shape anisotropy, composition and surface modification and is discussed in 
chapter 3. Increasing the size, increases the magnetic saturation leading to 
improved heating characteristics. Therefore we have synthesized 10 nm 
superparamagnetic iron oxide nanoparticles (SPIONs) and 30 nm 
ferrimagnetic nanoparticles (FIONs). Different shapes of Fe3O4 
nanoparticles could result in distinct magnetic domain structures and 
hysteresis losses, which influence the heat dissipation of non- 
 




superparamagnetic nanostructures. We have thus synthesized 20 nm 
nanospheres, nanotetragons and nanohexagons. Changing the composition of 
Fe3O4 nanoparticles by doping with divalent ions like cobalt and nickel to 
form CoFe2O4 and NiFe2O4 nanoparticles has significant effect on the 
magnetic hyperthermia properties. Surface modification of Fe3O4 
nanoparticles improves the colloidal stability of the ferrofluid. Improved 
stability improves the heating efficiency of the ferrofluid system.  This thesis 
also focuses on the improvement of colloidal stability using biocompatible 
surface modifying agents like proteins and thereby increasing the heating 
efficiency of the nanoparticles. Thus the effect of size, shape, composition and 
surface modification of Fe3O4 nanoparticles on magnetic hyperthermia are 
discussed in the chapter 3 of the thesis. 
 
3) Magnetic metal oxides are intravenously injected into the bloodstream for 
theranostic applications like magnetic hyperthermia and MRI. Just like 
various physical and chemical parameters of the nanoparticles have 
significant effect on the biosystem, the biosystem also conversely 
influences the efficiency of the magnetic hyperthermia system. Though 
extensive research is done on the safety of magnetic nanoparticles and also 
magnetic hyperthermia, a detailed scientific report on the effect of AC 
magnetic field on the healthy and tumor tissue is not available. In chapter 
4, we have attempted to make the first detailed scientific study on the 
same. We have found that.the application of AC magnetic field influences 
the physiological ions in the biosystem. This in-turn causes enhanced 
temperature raise which contributes to the heating efficiency of magnetic 




nanoparticles inside the biosystem. If this is the case, there is much 
possibility that this will affect the viability of the healthy tissue. But as 
well discussed in many research papers, magnetic hyperthermia is not 
supposed to damage the healthy tissue. Though Enhanced Permeation and 
Retention capacity of tumor morphology leads to tumor cell necrosis and 
apoptosis, the reason for less or no damage to healthy tissue even under the 
influence of magnetic field and magnetic particles spans beyond it. We 
have found that physiological proteins shield effect of physiological ions 
and impose a shielding effect on the healthy tissue. Thus physiological 
proteins act as biosafety agents. Thus the influence of AC magnetic field 
and physiological components like ions and proteins on the heating 
efficiency of SPIONs is discussed in chapter 4. 
 
4) Synthesis of Gd2O3 nanoparticles as a T1 contrast agent for diagnostic 
application, MR imaging is explored in chapter 5.  A comparison between 
bare thioglycolic acid capped Gd2O3 nanoparticles and organic BSA 
conjugated Gd2O3 nanoparticles is discussed. In the later section of this 
chapter, in-situ photodegraded inorganic polyvinyl pyrrolidone coated 











5) Chapter 6 of thesis explores the fabrication of multifunctional iron oxide- 
gadolinium oxide nanoclusters which could be used as a single potential 
candidate for cancer theranostics. Hydrophilic iron oxide- gadolinium 
oxide (Io-Go) nanoclusters were fabricated. While Fe3O4 nanoparticles 
serve as potential magnetic hyperthermia and T2 magnetic resonance 
image contrast agents, the Gd2O3 nanoparticles of the Io-Go nanoclusters 
serve as potent T1 image contrast agents for magnetic resonance imaging. 





























Chapter 2 focuses on the synthesis of magnetic metal oxide (Fe3O4, Gd2O3, 
CoFe2O4, NiFe2O4) nanoparticles and their hydrophilic phase transfer. The 
characterization of the fabricated particles and the experimental set-ups for 
their applications. 
2.1 Synthesis of hydrophobic magnetic metal oxide nanoparticles 
Recent advancements in nanomaterials fabrication, employ physical and 
chemical methods to synthesize magnetic metal oxide (Fe3O4, Gd2O3) 
nanoparticles. The physical methods of fabrication, include pulsed laser 
deposition (PLD) [93], molecular beam epitaxy (MBE) [94] and magnetron 
sputtering, which are used for the thin film deposition. For biomedical 
applications, chemical and electrochemical synthesis of magnetic 
nanoparticles are used [95]. Chemical method are of high efficiency and low 
equipment cost. Since chemical synthesis can also produce various 
nanostructures (like nanocubes, nanospheres, nanoring, nanotube, nanorod, 
nanohexagon and nanodisc, etc.), it is widely adopted for the fabrication of 
different nanostructures. There are a number of chemical methods like co-
precipitation, thermal decomposition, micelle synthesis and hydrothermal 





















As shown in the above table, the co-precipitation is a facile way to synthesize 
Fe3O4 nanoparticles from aqueous Fe3+ salt solutions by the addition of an 
alkali under an inert atmosphere at room temperature or at elevated 
temperature (<90°C). Though the yield is highly scalable, the size distribution 
and shape control are a constraint. In contrast, the thermal decomposition 
method, based on the decomposition of organometallic precursors at high 
temperature (<320°C), could achieve very narrow size distribution and very 
good shape control. This makes this method is a standard chemical method for 
the synthesis of monodisperse magnetic metal oxide (Fe3O4, Gd2O3) 
nanoparticles. The microemulsion approach relies on the phenomenon that 
“water-in-oil” microemulsion can be formed when immicisible water is 
dispersed in a hydrocarbon based continuous phase. The few nanometers big 
water core could offers a suitable environment for controlled nucleation and 
growth of magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles [96].  
 





Though shape can be tuned through selective adsorption of molecules on to 
facets of the nanocrystal the size distribution of the final product is not as good 
as the thermal decomposition method. Furthermore, the yield is also quite low. 
Hydrothermal method renders high quality products with good size dispersion 
and shape control. But it is time consuming when compared to thermal 
decomposition method. In this thesis, we have fabricated magnetic metal oxide 
(Fe3O4, Gd2O3) nanoparticles by thermal decomposition method.  
 
Sun et al have reported a decomposition approach for the fabrication of size-
controlled monodispersed magnetite nanoparticles based on reaction between 
iron acetylacetonate and phenyl ether in the presence of oleic acid, and 
oleylamine. With the smaller magnetite nanoparticles as seeds, larger 
monodispersed magnetite nanoparticles of 20 nm in diameter were produced. 
This process does not require a size-selection procedure and is scalable [97]. 
The thermal decomposition of iron pentacarbonyl also produces iron 
nanoparticles. For instance, Hyeon et al have reported a synthesis of highly 
crystalline and monodispersed iron by the thermal decomposition of iron 
pentacarbonyl in the presence of oleic acid at 100°C [98]. Particle size and 
shape can be varied by controlling the experimental parameters. 
Decomposition of gadolinium acetate encapsulated in single wall carbon 
nanotubes produces Gd2O3 nanoparticles with a ultrasmall particle size of 2.3 
nm [99]. For the synthesis of ultra-small Gd2O3, the thermal decomposition 
route has been proved to be effective interms of particle quality with a 
controlled size and narrow distribution [100, 101].  
 





Though efforts have been made to transfer these as-synthesized nanoparticles 
from hydrophobic into hydrophilic phase for bio-applications [102, 103], most 
works still maintain oleic acid on the surface as it keeps the water molecules 
away from the Gd2O3 core, and thus contributes to the magnetic influence of 
Gd3+to the relaxation of protons. 
 
For all the above mentioned reasons, we have used thermal decomposition for 
synthesis of our magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles using 
iron/gadolinium acetylacetonate, oleic acid, olelylamine and benzyl ether. The 
oleic acid capped hydrophobic surface of the as-synthesized particles, offer a 
wide choice for surface manipulation for further biomedical applications. 
 
In this thesis, magnetic metal oxide (Fe3O4, Gd2O3, CoFe2O4, NiFe2O4) 
nanostructures were synthesized by the conventional thermal decomposition 
method for investigation. A simple schematic representation of the same is 
shown in Fig. 2.1. The potential application of these nanostructures were in 
magnetic hyperthermia and MRI. Therefore our aim was to fabricate magnetic 
metal oxide nanostructures which give high SAR value and relaxivity. The 
size and shape of products were controlled by adjusting reaction conditions, 












Fig. 2.1: Schematic representation of thermal decomposition method. 
 
2.1.1 Synthesis of Fe3O4 nanostructures 
 
The Fe3O4 nanoparticles of different sizes and shapes were chemically 
synthesized by the thermal decomposition method as described elsewhere 
[104, 105]. This is a highly preferred method for producing Fe3O4 
nanoparticles of uniform size, shape and monodispersity. The chemical 
composition and physical parameters were modified as per the requirements. 
 
Octahedral Fe3O4 nanoparticles 
 
Octahedral Fe3O4 nanoparticles of 10 nm size were synthesized. Fe3O4 
nanoparticles of size ≤ 10 nm are considered to be superparamagnetic and 
hence we call them as superparamagnetic iron oxide nanoparticles (SPIONs). 





Briefly, 6 M  iron (III) acetylacetonate was added to 6 mM oleicacid and 20 
ml benzyl ether and heated under nitrogen purging to 110°C in order to 
remove moisture and maintained at the temperature for 1 hour. The 
temperature was later increased to 160°C and kept there for 30 minutes to 
initiate nucleation. The reaction was maintained at 280°C with reflux for upto 
30 minutes, to promote growth of the Fe3O4 nanoparticles. The size of the 
Fe3O4 nanoparticles depends on the duration the reaction is maintained at 
280°C. Increased duration increases the size of the particles. The particles 
were centriguded by adding ethanol and hexane thrice. The product was later 
dispersed and stored in chloroform. 
 
Spherical Fe3O4 nanoparticles 
 
Spherical Fe3O4 nanoparticles of 20 nm size were synthesized. Briefly, 2  g  
o f  iron (III) acetylacetonate was added to 10 mL of oleic acid and 10 ml 
Oleylamine and heated under nitrogen purging to 200°C inorder to remove 
moisture and initiate nucleation. The reaction was maintained at 200°C for 15 
minutes. The temperature was later increased to 320°C with reflux for upto 1 
hour, to promote growth of the spherical Fe3O4 nanoparticles.  
 
Hexagonal Fe3O4 nanoparticles 
 
Hexagonal Fe3O4 nanoparticles of 20 nm size were synthesized.  Briefly, 0 . 3  
m M  o f  iron (III) acetylacetonate and 0.3 mM of 1,2 hexadecanediol were 
added to 6mM of oleic acid and 10 mL of benzyl ether heated under nitrogen 





purging to 200°C inorder to remove moisture and initiate nucleation. The 
reaction was maintained at 200°C for 15 minutes. The temperature was later 
increased to 320°C with reflux for upto 1 hour, to promote growth of the 
hexagonal Fe3O4 nanoparticles.  
 
Tetragonal Fe3O4 nanoparticles 
 
Hexagonal Fe3O4 nanoparticlesof 20 nm size were synthesized.  Briefly,1.2 g 
of iron (III) acetylacetonate and 0.4 g of 1,2 hexadecanediol were added to 5 
mL of oleic acid, 10 mL oleylamine and 10 mL of benzyl ether heated under 
nitrogen purging to 200°C inorder to remove moisture and initiate nucleation. 
The reaction was maintained at 200°C for 15 minutes. The temperature was 
later increased to 320°C with reflux for upto 1 hour, to promote growth of the 
tetragonal Fe3O4 nanoparticles.  
 
Cubical Fe3O4 nanoparticles 
 
Cube shaped Fe3O4 nanoparticles of 20 nm size were synthesized.  Briefly, 2  
m M  o f  iron (III) acetylacetonate and 8 mM decanoic acid were added to 50  
mL diphenyl ether. The reaction mixture was heated under nitrogen purging to 
200°C inorder to remove moisture and initiate nucleation. The reaction was 
maintained at 200°C for 15 minutes. The temperature was later increased to 
320°C with reflux for upto 1 hour, to promote growth of the cubic Fe3O4 
nanoparticles.  
 









Cobalt Fe2O4 (CoFe2O4) were synthesized by thermal decomposition method. 
Briefly, 1mM of cobalt (II) acetylacetonate and iron (III) acetylacetonate was 
added to 2mM oleic acid, 0.64 mL olelylamine, 0.67 g 1, 2 hexadecanediol and 
30 mL phenyl ether. The reaction mixture heated under nitrogen purging to 
200°C for 15 min and refluxed at 320°C 1 hour, washed and stored.  
 
NiFe2O4 nanoparticles 
Nickel Fe2O4 (NiFe2O4) were synthesized by thermal decomposition method. 
Briefly, 1mM of Nickel (II) acetylacetonate and iron (III) acetylacetonate was 
added to 2mM oleic acid, 0.64 mL olelylamine, 0.67 g 1, 2 hexadecanediol and 
30 mL phenyl ether. The reaction mixture heated under nitrogen purging to 
200°C for 15 min and refluxed at 320°C 1 hour. The sample was washed by 
centrifuging with ethanol and hexane.  
2.1.3 Synthesis of ultra-small Gd2O3 nanoparticles 
Ultra-small Gadolinium oxide (Gd2O3) nanoparticles were also synthesized by 
thermal decomposition method. 1 mM gadolinium acetate was added to 18 
mM oleic acid and 60 mM oleylamine.  The reaction mixture was heated at 
120°C in a for 1 hour under mild nitrogen purging remove moisture. Later the 
temperature was raised to 280°C immediately and maintained at the same for 





6 hours. After cooling down, the mixture was treated with ethanol for the 
particles to precipitate. The nanoparticles were collected by centrifuging and 
washed with toluene and ethanol thrice. The final product was stored in 20 ml 
toluene or chloroform. 
2.2 Hydrophilic and biocompatible phase transfer of magnetic metal 
oxide nanoparticles 
 
The as-synthesised Fe3O4 nanoparticles were hydrophobic in nature due to the 
oleic acid capping. The magnetic metal oxide (Fe3O4, Gd2O3) have to be 
converted to hydrophilic phase so as to use it for invitro and invivo 
applications. 
 
As the magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles are usually 
administered intravenously or intra-arterially. Biocompatibility and prolonged 
blood circulation form the basis for the development of targeted magnetic 
hyperthermia system. This can be achieved by various surface 
modification/functionalization strategies. As per the desired biological 
application, magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles are rendered 
biocompatibility by different types of surface modifying agents like 
polymers, surfactants, biomolecules etc [106-108]., The magnetic suspensions 
have high magnetic susceptibility and zero coercive force with a magnetic 
core and hydrophilic surface, as shown in Fig. 2.2. Apart from rendering 
hydrophilicity and/or biocompatibility, they also help prevent agglomeration 





and hence enhance the heating characteristics for magnetic hyperthermia and 
signalling for MRI applications. 
 
 
Fig. 2.2: Schematic representation of ferrofluid. The fluid consists of small 
magnetic particles dispersed in a liquid (left). Each particle consists of a single 
domain iron oxide core grafted with surfactant (right). 
 
 
2.2.1 Surfactant coating  
 
Cetyl Trimethyl Ammonium Bromide (CTAB)  
 
The strategy of phase transfer using additional hydrophilic molecular layer 
over the original ligand (oleic acid) of magnetic metal oxide (Fe3O4, Gd2O3) 
nanoparticles was used in this approach. Cetyl Trimethyl Ammonium 
Bromide (CTAB) is a quarternary salt whose hydrocarbon chains adsorb onto 
the oleic moiety of the magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles, 





allowing the cationic ammonium moiety to face out into the solution, making 
the Fe3O4 nanoparticles hydrophilic [109]. A schematic representation of the 
same is shown in Fig. 2.3. In our experiments, the cationic CTAB was coated 
over the oleic acid capped, as-synthesized magnetic metal oxide (Fe3O4, 
Gd2O3) nanoparticles. Briefly, 0.1 M of CTAB was added to 10 mg magnetic 
metal oxide (Fe3O4, Gd2O3) nanoparticles. The mixture was vortexed and 
heated to 80°C. The reaction was stopped after 3 hours and washed. 
  
 





PEI is anionic polymer with negative surface charges. PEI was used to coat 
around the oleic acid capped 1 mg magnetic metal oxide (Fe3O4, Gd2O3) 
nanoparticles. Briefly, 10 mg/mL sample and 100 mg PEI were vortexed 





together in water. Later the reaction mixture was maintained at in water vortex 
sonicate at 80°C for 2 hours. The product was centrifuged and dispersed well 
in water. A schematic representation of the same is shown in Fig. 2.4 
 
 





2.2.2 Ligand exchange reaction 
 
In the ligand exchange strategy, the hydrophilic ligand with more affinity 
towards the inorganic magnetic metal core replaces the original hydrophobic 
ligand capping the magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles, thus 
rendering hydrophilicity [110]. In our experiments, the hydrophobic oleic 
moiety capping the magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles is 
replaced by the silane group of (3-Aminopropyl) trimethoxysilane (APTMS) 
and thiol group of thioglycolic acid (TA).  





(3-Aminopropyl) trimethoxy silane (APTMS) 
 
The silane group of APTMS was exchanged for oleic moiety on the magnetic 
metal oxide (Fe3O4, Gd2O3) nanoparticles. The amino groups are thus exposed 
out, causing rendering hydrophilicity. Briefly, 1 mg magnetic metal oxide 
(Fe3O4, Gd2O3) nanoparticles were dispersed in 10 ml toluene. To the 
dispersion, 90µL of APTMS was added and vortexed thoroughly. The mixture 
was kept in the shaker at room temperature for 72 hours for the ligand 
exchange reaction to take place. The reaction mixture was washed with 
ethanol and later with distilled water. The product was found to be well 
dispersed in water as the hydrophilic amino side faces the solvent. A 
schematic representation of the same is shown in Fig. 2.5. 
 











Thioglycolic acid (TA) 
The thiol group of TA was exchanged for oleic moiety on the magnetic metal 
oxide (Fe3O4, Gd2O3) nanoparticles. The amino groups are thus exposed out, 
causing rendering hydrophilicity. Briefly,1 mg magnetic metal oxide (Fe3O4, 
Gd2O3) nanoparticles were dispersed in 10 ml toluene. To the dispersion, 0.3 
mM TA was added and vortexed thoroughly. The mixture was kept in the 
shaker at room temperature for 24 hours for the ligand exchange reaction to 
take place. The reaction mixture was washed with ethanol and later with 
distilled water. The product was found to be well dispersed in water as the 
hydrophilic carboxy group faces the solvent. A schematic representation of the 
same is shown in Fig. 2.6. 
 









Poly Vinyl Pyrrolidone (PVP) 
PVP is a neutral polymer. PVP of molecular weight 40000 was used to coat 
the magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles. 0.02 mM of PVP was 
added to 0.25 mM of the magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles 
stock solution in toluene and 1:1 volume ratio of dimethyl formamide 
/dichloromethane (volume ratio of 1:1) were mixed and refluxed at 80°C for 
12 hours. The reaction mixture was cooled down and added dropwise to 130 
ml diethyl ether and stirring rigorously. The white precipitate was collected by 
centrifugation. The product was washed with toluene and diethyl ether thrice 
and the final product was suspended in DI water. A schematic representation 
of the same is shown in Fig. 2.7.   
 
 
Fig. 2.7: Schematic overview of PVP capping over metal oxide (Fe3O4, Gd2O3) 
nanoparticles.  
 





Later in situ photodegradation of the capped PVP was done. 10 mL of 1mM 
PVP capped Gd2O3 nanoparticles was diluted upto a volume of 250 mL.  UV 
irradiation was performed for upto 4 hours. The UV lamp was turned off after 
every 15 minutes and allowed to cool down for 15 minutes.  The samples were 
retrieved every 30 minutes of UV irradiation, inorder to measure the 
hydrodynamic radius, so as to confirm the photodegradation of PVP chains. 
 
2.2.3 In situ polymerization reaction 
 
Dopamine was conjugated over TA capped magnetic metal oxide (Fe3O4, 
Gd2O3) nanoparticles and allowed for in situ polymerization. Briefly, 6 mg 
dopamine was added to 10 mM PBS at pH 8.5. This mixture was added to 5 
mg of nanoparticles and incubated in shaker overnight for conjugation and in 
situ polymerization. The product was centrifuged and dispersed in water. A 

















Fig. 2.8: Schematic overview of in situ polymerization of dopamine over 
metal oxide (Fe3O4, Gd2O3) nanoparticles. 
 
2.2.4 Biocompatible phase transfer 
The APTMS capped magnetic metal oxide (Fe3O4, Gd2O3) nanoparticles have 
exposed amino groups which form strong amide bond with the carboxylic 
groups on the BSA by the EDC method [111]. Briefly, 26 mM EDC and 10 
mM NHS was prepared in MES (2-(N-morpholino) ethane sulfonic acid) 
buffer. 200 µL of EDC / NHS / MES mixture was added to 1 mL BSA (2 
mg/mL) to activate the carboxylic group. 2 ml of APTMS-iron oxide 
nanoparticles were dispersed in 1xPBS (0.1 mg/mL). The pH was maintained 
around 7.2-7.4. Both the solutions were then mixed and left in the shaker 
overnight at room temperature. A schematic representation of the same is 
shown in Fig. 2.9. 







Fig. 2.9: Schematic overview of albumin conjugation over metal oxide (Fe3O4, 
Gd2O3) nanoparticles.  
 
 
2.3 Characterization techniques 
A series of techniques were employed for the characterization of the magnetic 
metal oxide (Fe3O4, Gd2O3) nanoparticles. The morphology of the 
nanostructures was studied by transmission electron microscopy (TEM).  The 
crystallographic structure and purity was investigated by X-ray diffraction 
(XRD) and Selected Area Electron Diffraction (SAED) attached to TEM. The 
magnetization saturation of magnetic metal oxide (Fe3O4, Gd2O3) 
nanoparticles was measured by vibrating sample magnetometer (VSM) and 
Superconducting quantum interface devices (SQUID). The particle size 
distribution, stability and surface charge of the hydrophilic particles were 





investigated by a dynamic light scattering (DLS) system. The chemical 
bonding of the surface modified magnetic metal oxide (Fe3O4, Gd2O3) 
nanoparticles was interpreted by Fourier Transform InfraRed (FTIR) 
spectrometer. The conjugation of biomolecules to the magnetic metal oxide 
(Fe3O4, Gd2O3) nanoparticles was confirmed using Ultra Violet 
Spectrophotometer. The magnetic hyperthermia properties of magnetic metal 
oxide (Fe3O4, Gd2O3) nanoparticles were characterized by a heat induction 
machine. Table 2.2 lists the make and model of the above listed instruments  
Table 2.2: Make and Model of instruments used in this thesis 
S.No. Characterization Technique Make and Model 
1 Transmission Electron Microscopy (TEM) JEOL 2010/3010 
2 X-Ray Diffractometer (XRD) Bruker D8 Advance 
3 Vibrating Sample Magnetometer (VSM) Lakeshore 7404 
4 Superconducting Quantum Interface Device (SQUID) Quantum Design, MPMS XL-5 
5 Dynamic light scattering (DLS) Malvern Zetasizer Nano-ZS 
6 UV/Vis spectroscopy Shiamadzu –UV-1601 
7 Confocal Microscopy Olympus Fluoview FV1000 





8 Flow cytometry Flouview FV4 
9 Heat induction (Magnetic Hyperthermia) Shenzhen Shuangping, SPG-10-II 
 
2.3.1 Transmission electron microscopy (TEM) and Selected Area 
Electron Diffraction (SAED) 
Transmission electron microscopy (TEM) is the analytical tool to investigate 
morphology of samples. Generally, TEM is used to investigate crystal 
orientation, crystal structure, dislocations, composition, etc., The main 
components of a TEM system are electron gun, a condenser lens system, 
objective and intermediate lenses, a sample chamber, projector systems, 
vacuum systems and a holder that used to insert or remove samples [112]. In a 
TEM, a ultra-thin sliced sample of thickness about 100 nm is exposed to a 
parallel high-energy electron beam (100-400 KeV), so as to allow the 
electrons to pass through the sample easily. Apart from the electrons passing 
through the sample, some electrons are scattered to certain angles due to 
diffraction by atoms of sample. The bright-field and dark-field modes are the 
imaging methods in TEM.  
Fig. 2.10 shows the schematic illustration of TEM in Bright field mode. As 
shown in the figure, an objective aperture is positioned on-axis with the 
transmitted beams and transmitted electrons are allowed to pass through and 
contribute to the image. For the dark-field imaging, the aperture is placed off- 





axis from the transmitted beams only allowing the diffracted electrons to pass 
through. The dark-field mode is to study crystalline grains and defects. In 
addition, a TEM could perform the selected area electron diffraction (SAED) 
pattern.  
 
Fig. 2.10: Schematic illustration of working principle of Transmission 
Electron Microscope [107]. 
 
 
For a single crystalline material, the image on the screen is a series of spots, 
each referring to a satisfied diffraction condition of the sample's crystal 
structure. For a polycrystalline material, a series of rings would be observed. 
According to the diffraction pattern, the inter-planar distance is given by 
equation 2.1,  
 





dhklR = Lλ                            (2.1) 
where, dhkl - inter-planar distance of reflecting planes {hkl}, R - the distance 
between the center spot on the focal plane and diffracted spot, L - distance 
between focal plane and sample, λ -  the wavelength of the electron beam.  
The SAED can be used to identify the lattice parameters and crystal structure. 
The operating voltage of TEM is 300 kV. Samples were prepared for imaging 
by drying nanoparticles on a copper grid coated with a thin layer of carbon. 
2.3.2 X-Ray diffraction (XRD) 
XRD is the major technique for determining the atomic and molecular 
structure of a crystal. It is a non-destructive technique used for the 
determination of lattice constants, crystalline phase, grain size, preferred 
orientation strain, thermal expansion, etc. The XRD is principled Bragg's law, 
proposed by English physicists William Lawrence Bragg in 1913. As shown in 
Fig. 2.10, the crystal is made of a discrete parallel planes separated by a 
constant distance. When the phase shift is a multiple of 2, the interference is 
constructive. Therefore, when Bragg's Law shown by equation 2.2 is satisfied 
diffraction takes place [114] 
 
2d sinθ = nλ            (2.2) 
 
where, n - an integer corresponding to the order of diffraction, λ - the 
wavelength of incident X-ray, d-the inter-planar distance of reflecting planes 
and θ-the relative angle between the reflecting planes and incident wave. 











2.3.3 Vibrating sample magnetometer (VSM) 
VSM is a basic technique to measure magnetostatic properties of magnetic 
materials. VSM works on Faraday's law of electromagnetic induction. 
According to which the induced electromotive force (voltage) V(t) in any 
closed electrical circuit is proportional to the rate of the change of magnetic 
flux dΦ/dt through the circuit [116]. This is given by the equation 2.3, 
V(t) = - C · dΦ/ dt             (2.3) 
Where C is a constant 
Fig. 2.12 represents a schematic illustration of VSM system. The sample is 
attached on a non-magnetic holder and placed between the two 





electromagnets. The sample is then sinusoidally oscillated by a vibrator made 
of piezoelectric material. The oscillation induces the change of magnetic flux 
through pick-up coil and in turn inducing an electrical signal in the coils. This 
electrical signal is measured by a lock-in amplifier and transferred to 
magnetic moment of the sample since the amplitude of the signal is 
proportional to magnetic moment of sample. Hysteresis loop is got by 
measuring the sample in the external applied field which is continuously 
changed from a maximum positive field to negative field and back to the 
maximum positive field.  
 
Fig. 2.12: Schematic illustration of working principle of Vibrating Sample 
magnetometer [117]. 
 
2.3.4 Superconducting Quantum Interface Device (SQUID)  
SQUID is a highly sensitive magnetometer for magnetic properties 
investigation. It is used to measure even mild magnetic moment. The key 





component of the SQUID is a superconducting material loop with one or 
more weak links, forming several Josephson junctions. Superconducting 
material found in 1911 means that at below transition temperature, it exhibits 
a resistant-less state. The Cooper pair transportation in a circuit proposed by 
Leon Cooper in 1956 explains this phenomenon. Cooper pair is a pair of 
electrons (or other fermions) that coupled each other by an arbitrarily small 
attraction. In addition, the weak links comprise of a thin insulating barrier or 
a non-superconducting metal. SQUID works on the principle that when a 
current flows between two superconductors isolated from each other by a 
weak link layer (Josephson junctions) [118], quantum tunneling of Copper 
pairs across the gap occurs. SQUID utilizes this the property of Josephson 
Junctions to detect minute deviations in magnetic flux, which induces a 
current in the superconductor loop. By detecting the resulting electrical 
signal, the magnitude of the magnetic flux can be obtained. The set-up of 
SQUID system is depicted in Fig. 2.13. The Dewar shield helps to eliminate 
the, ambient electronic noise, thermal radiation and external magnetic 
signals. The sample was inserted into a non-magnetic straw (Quantum 
Design). Before starting measurement, the magnet was reset in order to 
remove the remnant magnetic field trapped in the superconducting coils. 
 






Fig. 2.13: Schematic illustration of working principle of Superconducting 
Quantum Interface Device [119]. 
 
2.3.5 Fourier Transform Infrared Spectroscopy (FTIR) 
FTIR technique helps to characterize and analyse the structure and chemical 
composition of the sample. The light passes through a beamsplitter, which 
sends the light bi-directionally at right angles.  One beam goes to a stationary 
mirror and gets back to the beamsplitter while the other hits a moving mirror.  
When both the beams meet up at the beamsplitter, they recombine, but the 
difference in their path lengths create constructive and destructive interference 
and thus an interferogram is obtained [120]. When the recombined beam 
passes through the sample, it absorbs all the different wavelengths 
characteristic to its spectrum, while this subtracts specific wavelengths from 
the interferogram. The detector  






now reports differences in time and energy for all wavelengths 
simultaneously. The schematic diagram is given in Fig. 2.14.  
 
Fig. 2.14: Schematic illustration of principle of Fourier Transform Infrared 
Spectroscopy [121]. 
 
Fourier transform allows the conversion of an intensity vs time spectrum into 
an intensity vs frequency spectrum. The Fourier transform is given by 
equation 2.4. 
        (2.4) 
 
Where, A(r) and X(k)- frequency domain and time domain points, 
respectively. 
 





2.3.6 Dynamic light scattering (DLS)  
DLS is the technique to determine the size distribution of small particles in 
suspension [122].  Fig. 2.15 illustrates a DLS set-up. The light from laser 
passes through a polarizer and defines polarization of the incident beam. This 
beam later impinges on the scattering particle. The catered light passes 
through an analyzer, selecting a certain polarization, and then enters the 
detector where a time-dependent fluctuation in the scattering intensity is 
recorded. The dynamic information of the particles is derived from an 
autocorrelation of the intensity trace recorded during the experiment. The 
stability and surface charge of the colloid was also proved by DLS 
measurement. 
 












2.3.7 UV/Vis spectroscopy  
 
UV is used  in  analytical chemistry for the quantitative determination of 
different materials like transmission metals, biomacromolecules etc., It 
measures the intensity of light passing through a sample and compares the 
same with the initial intensity before passing through the sample [124]. The 
ration between the final and initial intensity is expressed as percentage 
transmittance. The absorbance A is based on the transmittance given by the 
equation 2.5, 
A= -log (%T/100%)           (2.5) 
Where, % T – transmittance. 
 
The basic parts of the UV spectrophotometer are a light source, diffraction 
grating in a monochromator, a holder for the sample and a detector. The 
radiation source is often a Tungsten filament (300-2500 nm), a deuterium arc 
lamp, continuous over the ultraviolet region. The detector is a photodiode. The 
scanning monochromator moves the diffraction grating to "step-through" each 
wavelength so as to measure the intensity as a function of wavelength.  
Samples are placed in a cuvette with an internal width of 1 cm, which is the 
path length L in the Beer-Lambert law. The Fig. 2.16 gives a schematic 
















2.3.8 Confocal microscopy 
 
In a confocal microscope, the illumination share a common focal plane with 
detection light paths by 2 pinholes that are equidistant to the specimen as 
shown in Fig. 2.17. Usually, Krypton/Argon and Helium/Neon mixed gas 
lasers are used that give a range of distinct wavelengths. This light is passed 
through a pinhole and reflected by a beamsplitter to the objective lens and 
specimen [126]. The beamsplitter which is a dichroic filter acts as a mirror for 
the excitation. Hence, the emitted light from the specimen goes through the 
beam splitter to the detection pinhole and the detector. The Fig. 2.17 gives a 
schematic representation of the same. 
 
 






Fig. 2.17: Schematic illustration of principle of confocal microscopy [127]. 
 
 
2.3.9 Flow cytometry 
Flow cytometry is used to measure the optical and fluorescence characteristics 
of single cells. The fluorescent molecules are excited to a higher energy state, 
when labeled cells are passed through a light source [128]. The fluorochromes 
emit light energy at higher wavelengths when they return to their resting state. 
Commonly used dyes for cytometry are propidium iodide, phycoerythrin, and 
fluorescein etc. Cells in suspension are streamed by isotonic fluid that creates 
laminar flow, permitting the cells to pass individually through an interrogation  
 





point. At the interrogation point, a beam of monochromatic light from a laser, 
intersects the cells. Emitted light is given off in all directions and is collected 
by optics that direct the light into a series of dichroic mirrors that isolate 
particular wavelength bands. The light signals are detected by photomultiplier 
tubes. The resulting information is displayed in histogram. Fig. 2.18 is a 
schematic diagram of flow cytometer.  
 




2.3.10 Heat Induction 
The principle of magnetic hyperthermia is based on the fact that the magnetic 
nanoparticles, under an alternating magnetic field will generate heat which kill 
the tumor cells. Magnetic hyperthermia system includes AC power supplier, 
copper coil and a temperature measurement system, as shown in Fig 2.19.   







Fig. 2.19: Schematic illustration of Magnetic hyperthermia set-up. 
 
The AC power supplier generates AC current which goes through the copper 
coil to generate an AC magnetic field and the amplitude of the field in the 
center of coil is given by equation 2.6, 
                   (2.6) 
 
Where, µ - vacuum permeability, I -current going through the coil, N -  total 
number of turns and L- length of coil. Under the induction field, the samples 
in the coil generate heat that increases the temperature of sample, which is 
recorded by the temperature meter.  
To evaluate the heat dissipation efficiency, specific absorption rate (SAR) 
value was calculated by equation 2.7, 
 






     (2.7) 
 
Where, C -specific heat of water (4.18 J/g °C), - initial slope of the time-
dependent temperature curve, CFe- weight fraction of magnetic element (i.e., 
Fe) in the sample. It should be noted that the maximum product of field 
amplitude and frequency (Hxf) should be below 4.5x1010 Am-1s-1 [130] so as 
to avoid non-selective heating of both cancerous and healthy tissue due to 
eddy currents [131].  
 
2.3.11 Magnetic Resonance Imaging (MRI) 
The principle behind MRI is the directional magnetic field associated with 
charged particles in motion as shown in Fig. 2.20. As nuclei are charged 
particles, the precession of the same produces a small magnetic moment. 
When a human body is placed in a magnetic field, the free hydrogen nuclei 
align themselves parallel to the magnetic field. The nuclei precess about the 
magnetic  
 
field direction like gyroscopes and is called Larmor precession [132].  The 
frequency of the same is proportional to the applied magnetic field strength as 
expressed as Larmor frequency given by the equation 2.8, 
ω = γB         (2.8) 
where,  γ - gyromagnetic ratio and B - strength of the applied magnetic field.  






Fig. 2.20: Schematic illustration of principle of MRI [133]. 
 
 
To obtain an MR image, the object is placed under a uniform magnetic field of 
0.5 to 1.5 Tesla. Once the Radio Frequency signal is removed, the nuclei 
realign themselves such that their net magnetic moment is again parallel 
with magnetic field. This return to equilibrium is referred to as relaxation. The 
longitudinal relaxation time is T1 and the transverse relaxation time is T2. 
T1 measures the time required for the magnetic moment of the displaced 
nuclei to realign itself with Bo. T2 indicates the time required for the response 
signal from a given tissue type to decay. 






























This chapter discusses our attempt to fabricate Fe3O4 nanoparticles for improved 
heating efficiency and biocompatibility for magnetic hyperthermia application. 
Magnetic hyperthermia is a promising cancer treatment strategy to selectively kill 
the tumor cells. When the temperature of the tumor site reaches 42℃, the tumor 
cell apoptosis and subsequent necrosis occurs. This is because of the enhanced 
permeation and retention characteristic of the tumor site [134, 135]. In order to 
minimize the adverse side effect to patients, for clinical application, the Fe3O4 
nanoparticles should not only be biocompatible but also possess high heating 
efficiency inorder to offer the flexibility to reduce particle concentration. Thus 
this chapter focuses on the experiments to try to improve the heating efficiency 
without compromising on the biocompatibility and the vice-verse. 
 
Size of the Fe3O4 nanoparticles is the first and foremost factor in determining the 
heating efficiency. This is a widely researched topic in the field of magnetic 
hyperthermia. Increase in size increases the SAR value, as bigger Fe3O4 
nanoparticles show higher saturization magnetization [136]. On the flip-side, 
bigger nanoparticles are also expected to cause cytoxicity and are difficult to be 
excreted out of the biological system. We have attempted to fabricate optimum 
size of Fe3O4 nanoparticles of 10 nm superparamagnetic iron oxide nanoparticles 
(10 nm SPIONs) and 30 nm ferrimagnetic iron oxide nanoparticles (30 nm  
 




FIONs), without compromising on the heating characteristics and 
biocompatibility. This is discussed in the first section. The next section explores 
the convenient shape of the Fe3O4 nanoparticles. Different shapes prefer different 
magnetic domain structures for inorder to minimize the energy, leading to 
enhanced variation in both static and dynamic magnetic properties. Nanospheres, 
nanohexagons and nanotetragons each of size 20 nm Fe3O4 nanoparticles were 
fabricated, due to the ease of synthesis and reproducibility of 20 nm nanoparticles. 
Varying the composition of Fe3O4 nanoparticles by partially replacing the ferrous 
ions with divalent like cobalt and nickel with higher anisotropy, increases the 
magnetic properties even at superparamagnetic regime. Difference in geometrical 
arrangement of nanoparticles in suspensions also influences the magnetization. 
The third section explores the fabrication of Fe3O4 nanoparticles with varying 
composition using cobalt and nickel.  
 
After discussing size, shape and composition of Fe3O4 nanoparticles for 
improving heating efficiency, the last section discusses about enhancing both the 
biocompatibility and heating efficiency of Fe3O4 nanoparticles combinatorially by 
albumin conjugation. Extensive research has been done to improve the 
biocompatibility and blood circulation of iron oxide nanoparticles by numerous 
surface modification and functionalization strategies for various biomedical 
applications [137-139]. Similarly, various attempts have been made to enhance 
the Specific Absorption Rate (SAR) value of the iron oxide nanoparticles by  
 




controlling the aggregation, saturation magnetization, anisotropy, etc., [140, 
141]. The size and shape of the iron oxide nanoparticles can also be controlled 
inorder to improve the SAR value and thereby enhance the heating characteristics 
[142]. Achieving both biocompatibility and improved heating efficacy without 
compromising on either factor poses a huge challenge in the research of clinical 
magnetic hyperthermia. Biocompatible Fe3O4 nanoparticles for magnetic 
hyperthermia using polymers like poly ethylene glycol (PEG), poly vinyl 
pyrolidone (PVP), poly ethyleneimine (PEI), biomacromolecules like proteins, 
aptamers, DNA, surfactants like CTAB etc., are well reported [143, 144]. 
Combinatorial approach to simultaneously improve the biocompatibility and SAR 
value using noble metal like Platinum coated iron oxide core-shell nanoparticles 
are also reported [145, 146]. Chemical surface modifying agents render good 
hydrophilicity and stability to the Fe3O4 nanoparticles. But they are cytotoxic 
when used beyond the optimum threshold level [147, 148]. Therefore 
biomacromolecules like DNA, proteins etc., are preferred surface 
functionalization agents. For our work, we have chosen Bovine Serum Albumin 
(BSA) as the biocompatibility agent. Albumin, is a versatile protein which forms 
almost 55% of blood plasma protein content and helps to maintain the pH and 
osmotic pressure of blood [149, 150]. Thus BSA conjugation improves the 
stealth characteristics of iron oxide nanoparticles and hence prolongs the 
blood circulation time [151, 152]. BSA is also reported to raise the temperature 
of a nanoparticle system under an applied AC magnetic field by the formation  
 




of isotropic clusters [153]. Previous reports of Human Serum Albumin 
(HSA)conjugated superparamagnetic iron oxide nanoparticles (SPIONs) by 
Keshavarz et al and BSA conjugated SPIONs by Samanta et al [154] also show 
that albumin conjugation improves the colloidal stability and thereby the SAR 
value for magnetic hyperthermia. In these reports SPIONs were synthesized by 
inorganic co-precipitation method and albumin was conjugated by physical 
adsorption method. Thus we have chosen BSA as our single preferred candidate 
for both improved biocompatibility and enhanced heating efficiency. Moreover 
ferrimagnetic iron oxide nanoparticles (FIONs) have higher saturation 
magnetization and hence better SAR value than SPIONs [155, 156]. The 
unique heat enhancement property of BSA adds further value to heating efficiency 
of FIONs. Therefore BSA and FIONs are the candidates of interest for the single 
combinatorial approach to address the challenges in magnetic hyperthermia. We  
have fabricated BSA conjugated SPIONs of size 10 nm and FIONs of size 30 nm 
using the highly preferred thermal decomposition method.[157, 158]. Two 
surface modifying agents viz, Cetyl Trimethyl Ammonium Bromide (CTAB) 
and 3-Aminopropyltrimethoxysilane (APTMS) were used to render preliminary 
hydrophilicity to the as-synthesized hydrophobic iron oxide nanoparticles and also 











Blood aggregation and haemolytic studies  
 
Erythrocytes were collected by centrifuging the blood of 5 weeks old SCID 
mice at 700 rpm. The pellet was re-suspended in saline at a ratio of 1:4. The 
test samples-  as- Fe3O4 nanoparticles, hydrophilic Fe3O4 nanoparticles and 
biocompatible Fe3O4 nanoparticles, each of ferric ion concentration 0.5 mg/mL 
were added to the erythrocytes and the samples were incubated at 37ºC for 2 
hours. Distilled water, which leads to 100% lysis was used as the positive 
control. 0.1 M NaCl was used as negative control, as it is isotonic with the 
intracellular solute concentration. Haemolysis of erythrocytes is due to the 
oxidative stress caused by the test samples on the erythrocytes. The stress 
ruptures the cell membrane of the erythrocytes and hence the haemoglobin 
(Hb) leaks out into the solution. The absorbance of the leaked haemoglobin was 
measured at 540 nm by UV–Vis spectrophotometer. % Haemolysis can be 
calculated using the formula, 
%Haemolysis [ At  An / Ac  An ] 100 
Where, At- absorbance of the test sample at 540 nm; An- absorbance of the 
negative control (0.1M NaCl) at 540 nm;  Ac- absorbance of the positive control 
(distilled water) at 540 nm. The haemolytic index was also calculated according 
to ASTM F756-00 standards, according to which, 0-2% is non-haemolytic; 2-
5% is mildly haemolytic and >5% is haemolytic [159]. 




Cell viability studies  
 
The healthy Baby Hamster Kidney (BHK) cells suspended in 1xPBS were co-
incubated with 100 µg/mL of samples for 24 hours at 37°C. The BHK cells after 
incubation were run under flow cyclometry. Dyes NucBlue (ThermoFischer 
Scientific) to stain the total nuclei of cells, AlexaFluor (Invitrogen) to stain the 
apoptotic cells green and Propidium Iodide (PI-ThermoFischer Scientific) to 
stain the nucleus of dead cells red were used to qualitatively visualize the cells.  
Briefly, to 1 mm2of the BHK cells, 2 drops of NucBlue, 2.5 µL of AlexaFluor 
and 0.5 µL of PI were added along with 100 µL binding buffer and were 
incubated at room temperature for 15 minutes. The reaction was stopped by 
adding excess binding buffer and the samples were run in flow cytometry. In the 
histogram comprises of 4 quadrants. Quadrant 1 (Q1) represents cells that have 
under gone complete necrosis; Quadrant 2 (Q2) represents cells at late stage 
apoptosis, wherein the cell membrane has ruptured; Quadrant 3 (Q3) represents 
cells at early stage apoptosis; Quadrant 4 (Q4) represents live cells. The BHK 
cells after incubation were also observed under confocal microscope (Olympus-









Magnetic hyperthermia experiments  
 
The magnetic hyperthermia studies, to calculate the Specific Absorption Rate 
(SAR) were carried out by placing the sample inside a copper coil generating an 
external AC magnetic field. The temperature raise due to 0.1 mg/mL each 
sample with respect to the time of exposure of the sample to an AC magnetic 
field at an amplitude of 32.4 kAm-1, frequency of 360 kHz and a magnetic field 
of 600 Oe was investigated. SAR is expressed as the heat released by the 
magnetic iron oxide nanoparticles under a magnetic field. The SAR value is 
calculated from the formula, 
 
 
Where, Cwat- specific heat of the medium (distilled water), 4.18 J /g/ ºC; ∆T/∆t- 
initial slope of the time-dependent temperature curve; CFe- concentration of ferric 
ions in the medium, 0.1 mg/mL. The concentration of ferric ions in the samples 
was determined using ICP-OES analysis (Perkin-Elmer Dual view Optima 5300 
DV ICPOES system). 
 
The effect of AC magnetic field and 0.1 mg/mL BSA conjugated 30 nm 
ferrimagnetic iron oxide nanoparticles (FIONs) on healthy liver tissue was 
studied. Liver was treated with 0.1 mg/mL sample and an applied AC magnetic  
 




field of 600 Oe (frequency 360 kHz), to bring a ΔT of upto 42°C-45°C. The 
healthy tissue before and after treatment were observed under confocal 
microscope (Olympus-FluoView, FV1000). Dyes NucBlue (ThermoFischer 
Scientific) to stain the total nuclei of cells, AlexaFluor (Invitrogen) to stain the 
apoptotic cells green and Propidium Iodide (PI-ThermoFischer Scientific) to stain 
the nucleus of dead cells red were used to qualitatively visualize the excised organ 
tissue. While the nuclei of the live cells are stained blue, the nuclei of completely 
dead cells (necrosis) appear pink. Briefly, to 1 mm2of the excised tissue, 2 drops 
of NucBlue, 2.5 µL of AlexaFluor and 0.5 µL of PI were added along with 100 
µL binding buffer and were incubated at room temperature for 15 minutes. The 
reaction was stopped by adding excess binding buffer and the samples were 
viewed under the confocal microscope. The images were later processed using the 
software IMARIS 8.0. Our preliminary studies are based on the qualitative 














3.3 Results and Discussion 
 
3.3.1 Fe3O4 nanoparticles of different sizes  
 
Synthesis and hydrophilic phase transfer of Fe3O4 nanoparticles of different 
sizes 
 
We have synthesized 10 nm and 30 nm Fe3O4 nanoparticles of octahedral and 
cubic geometry respectively. Fig. 3.1(a-i) shows the TEM image of the as-
synthesized hydrophobic oleic acid capped 10 nm Fe3O4 nanoparticles. We have 
synthesized 30 nm Fe3O4 nanoparticles. It is evident from the image that the 
Fe3O4 nanoparticles were monodisperse with uniform size distribution.  Fig. 
3.1(b) shows that the particles were mono crystalline and pure. Fig. 3.1(b-i) gives 
the SAED pattern of Fe3O4 nanoparticles corresponding to (111), (220), (311), 
(400), (422), (440) and (511). From Fig. 3.1(b-ii), the diffraction peaks can be 
indexed as cubic spinel Fe3O4 (JCPDS no.19-0629), corresponding to (220), 
(311), (400), (422), (511) and (440). The broad peaks of 10 nm Fe3O4 
nanoparticles and sharp peaks of 30 nm Fe3O4 nanoparticles also confirm the size 
of the particles. The saturation magnetization (Ms) value of the as- synthesized 
10 nm and 30 nm Fe3O4 nanoparticles are 45 emu/g and 87 emu/g respectively as 
shown in the Fig. 3.1(c-i). 30 nm Fe3O4 nanoparticles have a higher magnetic 
saturation which makes it our preferred candidate for magnetic hyperthermia  
 




application. The inset figure in Fig. 3.1(c-i), shows the coercivity exhibited by 30 
nm Fe3O4 nanoparticles (30 nm FIONs). SQUID magnetometer was used to 
further characterize ferrimagnetic behaviour of 30 nm FIONs. The magnetization 
hysteresis loops at different temperatures are shown in Fig. 3.1(c-ii). As observed 
from the loops, the coercivity increases as the temperature decreases. All our 
magnetization studies show the characteristic ferrimagnetic behaviour of 30 nm 
Fe3O4 nanoparticles. The temperature dependent Field Cooling (FC) and Zero-
Field Cooling (ZFC) magnetization were measured for the 30 nm Fe3O4 
nanoparticles (30 nm FIONs). The Verwey transition temperature (Tv) is the 
reflection point of the characteristic magnetization jump and is deduced from a 
ZFC plot derivative as shown in Fig. 3.1(c-iii). The Tv of the as-synthesized 30 
nm 30 nm Fe3O4 nanoparticles is around 115 K, which is very close to the 
characteristic Tv of 120 K for magnetite as reported extensively [160, 161]. The 
minor shift is commonly observed in magnetite (Fe3O4) nanoparticles. Also we 
further conclusively confirm that the as-synthesized 30 nm Fe3O4 nanoparticles 
are ferrimagnetic nature, in accordance to our extensive studies [162]. The higher 
magnetic saturation of 30 nm Fe3O4 nanoparticles make it our preferred candidate 
for magnetic hyperthermia application.  







Fig. 3.1: Characterization of as-synthesized Fe3O4 nanoparticles (a-i) TEM image 
of 10 nm SPIONs (a-ii) TEM image of 30 nm FIONs (b-i) SAED pattern of Fe3O4 
nanoparticles (b-ii) XRD plots of Fe3O4 nanoparticles 
 
 







Fig. 3.1: (c-i) saturation magnetization (Ms) of Fe3O4 nanoparticles. Inset image 
shows the coercivity of 30 nm FIONs (c-ii) magnetization hysteresis loops of 30 
nm FIONs at different temperatures (c-iii) Verwey transition temperature (Tv) of 
30 nm FIONs. 
 
The hydrophobic as-synthesized Fe3O4 nanoparticles were surface modified to 
hydrophilic phase using three different surface modifying agents- Cetyl Trimethyl 
Ammonium Bromide (CTAB), (3-Aminopropyl) trimethoxysilane (APTMS) and 
Polyethyleneimine (PEI). The FTIR plot in Fig.3.2(a-i) confirms that the CTAB 
was coated over the Fe3O4 nanoparticles. The peaks corresponding to 2900 1/cm 
is due to C- H stretching and 1440 1/cm is due to the scissoring vibration of 






methylene and asymmetric bending mode of the head [N(CH3)3] methyl group 
[163]. The FTIR peak corresponding to 592 1/cm in plot is related to the Fe–O 
group and thus confirm the existence of Fe3O4. For the APTMS coated Fe3O4 
nanoparticles, the peaks at 1700 1/cm and 1648 1/cm are due to the stretching 
vibration of C=O and stretching vibration of C=C bonds, respectively. The 
peaks at 1172 1/cm and 1017 1/cm are due to the stretching vibration of C-O. 
The asymmetric stretching vibration and scissoring bending vibration of CH2 
group is represented by peaks at 2926 1/cm and 1460 1/cm, respectively [164]. 
The FTIR peak corresponding to 592 1/cm in plot is related to the Fe–O group 
and thus confirm the existence of Fe3O4. This is evident from Fig. 3.2(a-ii)  For 
the PEI coated Fe3O4 nanoparticles, the peaks at 3420 1/cm is due to NH and 
peaks  corresponding to 2925 1/cm and 2852 1/cm are due to the asymmetric 
stretching vibration of CH2. The FTIR peak corresponding to 592 1/cm in plot is 
related to the Fe–O group and thus confirm the existence of Fe3O4. This is 
evident from Fig. 3.2(a-iii). Fig. 3.2(b-i) and 3.2(b-ii) shows the average 
hydrodynamic radius of the hydrophilic 10 nm and 30 nm Fe3O4 nanoparticles.  
 
As expected, due to their longer polymer chain length, PEI coated 10 nm and 30 
nm Fe3O4 nanoparticles have a bigger size of 21±2 nm and 52±2 nm respectively. 
The CTAB coated 10 nm and 30 nm Fe3O4 nanoparticles have an average 
hydrodynamic radius of 19±2 nm and 40±2 nm respectively. Since APTMS 
immediately caps the Fe3O4 nanoparticle surface, they have the smallest average 






hydrodynamic radius of 15±2 nm and 36±2 nm for 10 nm and 30 nm Fe3O4 
nanoparticles respectively. The hydrophilic Fe3O4 nanoparticles were stable even 
upto a period of 1 month, as shown in Fig. 3.2(b-iii). 
 
Fig. 3.2: Hydrophilic phase transfer of Fe3O4 nanoparticle (a-i) FTIR plot for 
CTAB coated Fe3O4 nanoparticles (a-ii) FTIR plot for APTMS capped Fe3O4 
nanoparticles (a-iii) FTIR plot for PEI coated Fe3O4 nanoparticles (b-i) Average 
hydrodynamic radius of  CTAB, APTMS and PEI coated 10 nm SPIONs (b-ii) 
Average hydrodynamic radius of  CTAB, APTMS and PEI coated 30 nm FIONs. 
Inset shows the 30 nm FIONs individually coated with APTMS and the stable 
APTMS-FIONs solution (b-iii) stability of hydrophilic Fe3O4 nanoparticles over a 















Cell viability studies of Fe3O4 nanoparticles of different sizes 
 
Fig. 3.3 shows the histogram of cell viability studies of 10 nm SPIONs and 30 nm 
FIONs. It is obvious from the Fig. 3.3(a) and 3.3(b) that there is no much 
difference in the cell viability between 10 nm and 30 nm Fe3O4 nanoparticles. 
While the 10 nm SPIONs show a viability of 99.4 % 30 nm FIONs show a 
viability of 99 %. There are more live cells in Q4 in both the histograms. While 
Q1 of Fig. 3.3(a) has almost no cells, Fig. 3.3(b) shows cells in Q1 and Q2, 
indicating that cells are starting to enter into late apoptosis and necrosis stage. 
This shows that, irrespective of the surface modifying agent used, the optimum 
size of Fe3O4 nanoparticles used for biomedical applications is between 10-30 nm. 
This is also the optimum size for magnetic hyperthermia applications, as Fe3O4 
nanoparticles lesser than 10 nm, do not have strong heating characteristics and 
Fe3O4 nanoparticles bigger than a core size 30 nm might pose cell cytoxicty and 
later difficulty in excretion from the biosystem.  
 







Fig. 3.3: Cell viability studies of Fe3O4 nanoparticles of different sizes a) 10 nm 
SPIONs- 99.4% viability b) 30 nm FIONs- 98% viability. 
 
Magnetic hyperthermia of Fe3O4 nanoparticles of different sizes 
 
As expected, the SAR value of the 30 nm Fe3O4 nanoparticles (FIONs) is higher 
than that of 10 nm Fe3O4 nanoparticles (SPIONs) irrespective of the surface 
modifying agent used, due to their higher magnetization. But the SAR value plot 
in Fig. 3.4 indicates that APTMS capped Fe3O4 nanoparticles shows slightly 
higher SAR value, this might be because of the smaller chain length of the same. 
The SAR values for APTMS capped 10 nm and 30 nm Fe3O4 nanoparticles are 
510 W/g and 1790 W/g respectively. The SAR values for CTAB coated 10 nm 
and 30 nm Fe3O4 nanoparticles are 300 W/g and 1725 W/g respectively and for 
PEI coated 10 nm and 30 nm Fe3O4 nanoparticles are 285 W/g and 1685 W/g 
respectively. The inset figure shows that the temperature raise (∆T) for 10 nm 






Fe3O4 nanoparticles is only around 1.5°C and 30 nm Fe3O4 nanoparticles is 4.8°C 
respectively for a 3 minute exposure to 600 Oe field.  
 
 
Fig. 3.4: SAR value comparison between hydrophilic Fe3O4 nanoparticles. Inset 
image shows the temperature raise comparison between 10 nm and 30 nm Fe3O4 












3.3.2 Fe3O4 nanoparticles of different shapes  
 
Synthesis and hydrophilic phase transfer of Fe3O4 nanoparticles of different 
shapes 
 
We have synthesized 20 nm Fe3O4 nanoparticles of spherical, hexagonal and 
tetragonal geometry respectively. Fig. 3.5(a) shows the TEM image of the as-
synthesized hydrophobic oleic acid capped Fe3O4 nanoparticles of different 
shapes. It is evident from the Fig. 3.5(a-i) and Fig. 3.5(a-ii) that the Fe3O4 
nanoparticles of spherical and hexagonal shapes respectively were monodisperse 
with uniform size distribution, while from Fig. 3.5(a-iii) the nanotetragons were 
not uniformly distributed interms of size and shape. We find the overall average 
size and shape of nanotetragon is 20 nm. The inset image shows the SAED 
corresponding to (111), (220), (311), (400), (422), (511) and (440) and confirms 
the crystal structure of the samples. The saturation magnetization (Ms) value of 
the as-synthesized nanotetragon was higher than that of nanosphere of and 
nanohexagon of as shown in Fig. 3.5(b). This might be because of the non-
uniform size and shape distribution.  Fig. 3.5(c) shows that the particles were 
monocrystalline and pure. This was measured using X-Ray Diffractometer (XRD, 
Bruker D8 Advanced Diffractometer System with Cu Ka (1.5418 A˚) source. The 
diffraction peaks can be indexed as cubic spinel Fe3O4 (JCPDS no.19-0629), 
corresponding to (220), (311), (400), (422), (511) and (440).  







Fig. 3.5: Characterization of as-synthesized 20 nm Fe3O4 nanoparticles of different 
shapes (a-i) TEM image of nanopsheres (a-ii) TEM image of nanohexagons (a-iii) 
TEM image of nanotetragons (a-ii) TEM image of nanohexagons (b) saturation 
magnetization (Ms) of Fe3O4 nanoparticles of different shapes (b) XRD plots of 




The hydrophobic as-synthesized Fe3O4 nanoparticles were surface modified to 
hydrophilic phase using (3-Aminopropyl) trimethoxysilane (APTMS) as our 
previous studies showed better stability and reduced average hydrodynamic radius 
for the same, with improved SAR value. Fig. 3.6 shows the average 






hydrodynamic radius of nanosphere is 28±2 nm, nanohexagon is 36±2 nm and 
nanotetragon 52±2 nm is respectively.  
 
Fig. 3.6: Average hydrodynamic radius of Fe3O4 nanoparticles of different shapes. 
 
 
Magnetic hyperthermia of Fe3O4 nanoparticles of different shapes 
 
Overall the Fe3O4 nanoparticles showed higher SAR value than 10 nm particles in 
the previous section. This is because as the size increases the magnetization 
increases and thus the SAR value. Fig. 3.7 shows that nanotetragons have a higher 






SAR value of 1865 W/g almost equivalent to that of 30 nm Fe3O4 nanoparticles 
from previous section. This is because of their non-uniformity leading to high 
magnetization. The nanospheres and nanohexagons have a SAR value of 910 W/g 















3.3.3 Fe3O4 nanoparticles of different composition- MetalFe2O4 (CoFe2O4, 
NiFe2O4) nanoparticles 
 
Synthesis and hydrophilic phase transfer of MetalFe2O4 (Co Fe2O4, NiFe2O4) 
nanoparticles 
 
Fig. 3.8 shows the TEM image of the as-synthesized hydrophobic nanoparticles of 
varied composition. For comparison sake we have synthesized 15 nm cubic Fe3O4 
nanoparticles as shown in Fig. 3.8(a-i). The inset image shows the High 
Resolution TEM (HRTEM) of Fe3O4 nanoparticles. Fig. 3.8(a-ii) shows the 
SAED pattern corresponding to (111), (220), (311), (400), (422), (440) and (511). 
Fig. 3.8(b-i) shows the TEM image of CoFe2O4.  The average size of the particles 
is 15 nm as seen from the TEM. The inset figure shows the HRTEM image of the 
same.  Fig. 3.8(b-ii) shows the SAED pattern corresponding to (111), (220), 
(331), (222) and (422). Fig. 3.8(c-i) shows the TEM image of NiFe2O4. The 
average size of the particles is 150 nm as seen from the TEM. Fig. 3.8(c-ii) shows 
the SAED pattern corresponding to (111), (311), (400) and (422). The NiFe2O4 
particles were almost 10 times bigger than the other two but since this section 
focuses on the composition and magnetization to anisotropy arising from 
composition, we used the NiFe2O4 particles for our studies. As seen from Fig. 
3.8(d) the Fe3O4 nanoparticles have higher magnetization of 55 emu/g when 
compared to 52 emu/g of CoFe2O4 and 40 emu/g of NiFe2O4.  The hysteresis loop 






of CoFe2O4 bigger than the other two compositions. Therefore it has better heating 
characteristics than the other compositions. 
 
 
Fig. 3.8: Characterization of as-synthesized MetalFe2O4 nanoparticles of different 
compositions (a-i) TEM image of 15 nm Fe3O4 nanoparticles (a-ii) SAED pattern 
of Fe3O4 nanoparticles (b-i) TEM image of 15 nm CoFe2O4 nanoparticles (b-ii) 
SAED pattern of CoFe2O4 nanoparticles (c-i) TEM image of 150 nm NiFe2O4 
nanoparticles (c-ii) SAED pattern of NiFe2O4 nanoparticles (b) saturation 










The particles were made hydrophilic by capping the same with APTMS. The 
average hydrodynamic radius of hydrophilic Fe3O4 nanoparticles is 21±2 nm 
CoFe2O4 nanoparticles is 25±2 nm and NiFe2O4 nanoparticles is 170±2 nm as seen 
in Fig. 9. 
 
Fig. 3.9: Average hydrodynamic radius of hydrophilic MetalFe2O4 nanoparticles 










Magnetic hyperthermia of MetalFe2O4 (CoFe2O4, NiFe2O4) nanoparticles 
 
 
The SAR value of the nanoparticles with varied composition is shown in Fig. 
3.10. CoFe2O4 nanoparticles of size 15 nm have a very high SAR value of 885 
W/g when compared to 625 W/g of 15 nm Fe3O4 nanoparticles. NiFe2O4 
nanoparticles have a low SAR value of 575 W/g. This is due to various factors 
like, bigger size and lower magnetization. It is widely considered that as the size 
of the Fe3O4 nanoparticles increases over an optimum size of 50 nm, the 
magnetization decreases. [165]. Also NiFe2O4 nanoparticles are widely considered 
to decrease heating efficiency than its counterparts discussed in this section [166, 
167]. CoFe2O4 nanoparticles are also biologically safe to be used for clinical 
applications [168]. The inset figure shows that the temperature raise (∆T) for 
CoFe2O4 nanoparticles is 2.8°C, Fe3O4 nanoparticles is 2.5°C and NiFe2O4 
nanoparticles is 3.2°C respectively.  







Fig. 3.10: SAR value of MFe2O4 nanoparticles of different composition. Inset 














3.3.4 Combinatorial approach to enhance the biocompatibility and magnetic 
hyperthermia performance 
 
The hydrophilic 10 nm superparamagnetic iron oxide nanoparticles (SPIONs) and 
30 nm ferrimagnetic iron oxide nanoparticles coated with CTAB and APTMS 
were used for our studies to enhance biocompatibility and heating efficiency 
combinatorially. 
 
Biocompatibility of BSA- Fe3O4 nanoparticles of different sizes 
 
It is also evident Fig. 3.11(a-i) and (a-ii) that there is no peak observed in the 
surface modified (hydrophilic) Fe3O4 nanoparticles, viz, CTAB- Fe3O4 
nanoparticles and APTMS- Fe3O4 nanoparticles. The characteristic peak of BSA 
is evident at 280 nm from Fig. 3.11(a-iii). The blue-shift in the UV-Vis spectrum 
shown in Fig. 3.11(a-iv) and 3.11(a-v) proves that the BSA is conjugated to 
the hydrophilic Fe3O4 nanoparticles and not merely present in the solution. The 
disturbances in the polypeptide environment within the BSA due to conjugation 
of the same to the surface modified Fe3O4 nanoparticles system is the reason 
behind the blue-shift. The Fig. 3.11(b) shows the zeta potential comparison of 
the BSA conjugated samples and non-conjugated samples. The reduction in 
surface charge after conjugating with BSA proves that BSA was conjugated 
with the surface modified Fe3O4 nanoparticles, as the anionic BSA reduces the 






zeta potential of the system. Fig. 3.11(c) show the average hydrodynamic radius 
of BSA-CTAB-SPIONs to be 40 nm,  BSA-CTAB-FIONs to be 80 nm,  BSA-
APTMS-SPIONs is 30 nm and BSA-APTMS-FIONs is 70 nm respectively. 
From the inset, it is evident that the FIONs are individually conjugated by 
the BSA and are well separated so as to prevent aggregation. The stability of the 
BSA conjugated iron oxide nanoparticles was enhanced when compared to the 
Fe3O4 nanoparticles without BSA conjugation, irrespective of the method of 
conjugation. This is evident from the DLS plot over a period of one month in 
Fig. 3.11(d). Thus the average hydrodynamic radius of BSA-SPIONs and BSA-
FIONs is around 35±4 nm and 75±4 nm respectively. The size range is narrower 
and is more stable than albumin conjugated SPIONS reported in previous studies. 
 
 







Fig. 3.11: Biocompatible Fe3O4 nanoparticles (a) UV-Visible spectrum of (i) 
CTAB- Fe3O4 nanoparticles (ii) APTMS-Fe3O4 nanoparticles (iii) characteristic 
peak of BSA at 280 nm (iv) blue-shift due to BSA-CTAB-Fe3O4 nanoparticles 
(v) blue-shift due to BSA-APTMS-Fe3O4 nanoparticles (b) Zeta potential 
comparison of hydrophilic and biocompatible Fe3O4 nanoparticles (c) Average 
hydrodynamic radius of BSA conjugated CTAB/APTMS coated SPIONs/FIONs. 
Inset shows the 30 nm FIONs individually conjugated with BSA and the stable 
BSA-APTMS-FIONs solution (d) stability of biocompatible Fe3O4 nanoparticles 
over a period of 1 month.  






Haemolytic studies of BSA-Fe3O4 nanoparticles 
 
The photos in Fig. 3.12(a)-(e) show the effect of test samples on erythrocytes. 
Fig. 3.12(a) shows aggregation of ruptured erythrocytes due to as-synthesized 
Fe3O4 nanoparticles -SPIONs and FIONs. Due to the high oxidative stress, 
haemoglobin was released into the solution as the ruptured erythrocytes settled 
down as debris. Fig. 3.12(b) and 3.12(d) show the haemolysis due to 
hydrophilic Fe3O4 nanoparticles-CTAB-Fe3O4 nanoparticles and APTMS-Fe3O4 
nanoparticles respectively. Mild haemolysis was observed in this case. The Fig. 
3.12(c) and 3.12(e) of BSA-CTAB-Fe3O4 nanoparticles and BSA-APTMS- 
Fe3O4 nanoparticles respectively show that there was a significant reduction in 
haemolysis after conjugating with BSA. There was almost no cell debris and 
therefore no haemoglobin leakage in the BSA conjugated test samples, which 
implies that cell lysis was almost nil in the same. This is the reason for the 
reduced absorbance at 540 nm. Fig. 3.12(f) graphically depicts the general 
mechanism of haemolysis in both as-synthesized and BSA conjugated iron oxide 
nanoparticles. The haemolytic studies were conducted as per the ASTM 
F756-00 standards. It is evident from Fig. 3.12(g) and 3.12(h) that the 
haemolytic index of the as-synthesized, hydrophobic SPIONs is 57% and that of 
FIONs is 78 %, both well above the 5 % standard, showing that they are highly 
haemolytic in nature. From Fig. 3.12(g) it is evident that the haemolytic index of 
CTAB-SPIONs is 28% when compared to 2.5 % of BSA-CTAB-SPIONs and 






CTAB-FIONs is 38% when compared to 2.2 % of BSA-CTAB-FIONs. Fig. 
3.12(h) shows that the haemolytic index of APTMS-SPIONs is 17 % and that of 
BSA-APTMS-SPIONs is 1.2 %. It also shows that the haemolyic index of 
APTMS-FIONs is 28% and that of BSA-APTMS-FIONs is 1.3%. This shows 
that BSA conjugation makes the Fe3O4 nanoparticles almost non-haemolytic 
nature, as the haemolytic index is ≤ 2%, irrespective of the method of 
conjugation. Surface modification by APTMS is non-haemolytic in nature, 
when compared to CTAB. This may be because the covalent bonding is 
stronger than physical adsorption and hence the particles are well conjugated 
with BSA. It is also observed that BSA-FIONs have biocompatibility similar 
to that of BSA-SPIONs, even though their size is bigger. Better 
biocompatibility for a bigger size is an added advantage, as FIONs have better 
magnetic properties to be used in magnetic hyperthermia experiments. 







Fig. 3.12: Haemolytic studies. Haemolytic effect of test samples (a) as-
synthesized Fe3O4 nanoparticles (b) CTAB-Fe3O4 nanoparticles (c) BSA-
CTAB-Fe3O4 nanoparticles (d) APTMS-Fe3O4 nanoparticles (e) BSA-APTMS-
Fe3O4 nanoparticles (f) Mechanism of haemolysis (g) Haemolytic index of the 
BSA conjugated CTAB- Fe3O4 nanoparticles (h) Haemolytic index of the BSA 
conjugated CTAB- Fe3O4 nanoparticles. 
 
 
Cell viability studies of BSA-Fe3O4 nanoparticles 
 
Since APTMS-FIONs and BSA-APTMS-FIONs showed reduced or nil 
haemolysis respectively, we performed cell viability studies using the same. 
The BSA conjugated APTMS-FIONs show a normalized viability range of upto  
120% (for 12.5 µg//mL and 25 µg//mL), when compared to the normalized 






100% of APTMS-FIONs (for 12.5 µg//mL and 25 µg//mL). Previous studies 
also show that addition of BSA conjugated SPIONs, without the external 
application of magnetic field show no harmful effect on cell viability [163]. It is 
also evident from Fig. 3.13(a) that the cell viability decreases as the 
concentration of FIONs in the test sample increases, as in 50 µg//mL and 100 
µg//mL. Fig. 3.13(b) and 3.4.4(c) shows the histogram of BHK cells after 
incubation with 100 µg//mL of APTMS-FIONs and BSA-APTMS-FIONs 
respectively. The cell viability of APTMS-FIONs is 98 % and BSA-APTMS-
FIONs is 99.5% as seen from the histograms. Though statistically the difference 
seems to be very insignificant, it is to be noted that Fig. 3.13(b) has more cells in 
late apoptosis (Q2) and a few cells in necrosis (Q1) stage. Fig. 3.13(c) sows 
almost no cells Q1 and Q2 showing that BSA conjugation significantly reduces 
the cytotoxicity of FIONs. The inset confocal images of Fig. 3.13(b) and 3.13(c) 
conform the same. This shows that BSA conjugated FIONs exhibit less or no 
cytotoxicity to healthy BHK cells.  
 







Fig. 3.13: Cell viability studies (a) The BSA conjugated APTMS-FIONs exhibit 
higher percentage of cell viability than the non-conjugated FIONs (b) APTMS-
FIONs are 98 % viable (c) BSA-APTMS-FIONs are almost 99.5 %. Inset figures 











From the haemolytic studies and the cell viability studies, it is evident that 
BSA conjugation improves the biocompatibility of the iron oxide nanoparticles 
system. BSA-FIONs show better results when compared BSA-SPIONs or as-
synthesized particles or the hydrophilic particles. Thus the first requisite for an 
efficient magnetic hyperthermia system is met out. 
 
Magnetic hyperthermia experiment of BSA-Fe3O4 nanoparticles 
 
The heating efficiency of the hydrophilic iron oxide nanoparticles and BSA 
conjugated iron oxide nanoparticles were studied by the magnetic hyperthermia 
experiments. Fig. 3.14(a) shows the temperature raise comparison of the 
CTAB- Fe3O4 nanoparticles and BSA- CTAB- Fe3O4 nanoparticles. From Fig. 
3.14(b) it is evident that the SAR value of CTAB-SPIONs is 270 W/g and that of 
BSA-CTAB-SPIONs is 540 W/g; CTAB- FIONs is 1750 W/g and that of 
BSA-CTAB-FIONs is 2200 W/g. Fig. 3.14(c) shows the temperature raise 
comparison of APTMS-Fe3O4 nanoparticles and BSA-APTMS- Fe3O4 
nanoparticles. A temperature raise of around 11ºC is observed in BSA-FIONs, 
when compared to the 3ºC raise shown by BSA-SPIONs in 3 minutes. Fig. 
3.14(d) shows that the SAR value of APTMS-SPIONs is 480 W/g when 
compared to 520 W/g of BSA-APTMS-SPIONs; APTMS-FIONs is 1700 W/g 
and BSA-APTMS-FIONs is 2300 W/g. It is observed that the covalent bond 
method using APTMS shows slightly better efficiency irrespective of the size of 






the particles due to the strong bonding between the hydrophilic iron oxide 
particles and the BSA and hence improved colloidal stability. It is evident that 
FIONs of 30 nm size show higher SAR value than SPIONS of 10 nm size, due 
to their higher saturation magnetization.  
 
Fig. 3.14: Heating characteristics a) Temperature raise comparison between 
BSA-CTAB-Fe3O4 nanoparticles and CTAB- Fe3O4 nanoparticles b) SAR 
value comparison between BSA-CTAB- Fe3O4 nanoparticles and CTAB- 
Fe3O4 nanoparticles c) Temperature raise comparison between  BSA-APTMS- 
Fe3O4 nanoparticles   and    APTMS- Fe3O4 nanoparticles d) SAR value 
comparison between BSA-APTMS-Fe3O4 nanoparticles and APTMS- Fe3O4 
nanoparticles. 
 






The SAR value plots show that, irrespective of the method of conjugation, 
BSA improves the heating efficiency of the system. While here we report 
the phenomenon, we are to further investigate the possible reasons behind 
this interesting phenomenon. It is stated elsewhere that isotropic clusters of 
BSA are formed under AC magnetic field [169]. Isotropic clusters might have 
possibly prevented the fibrous aggregation of iron oxide nanoparticles under 
the AC magnetic field. In general, fibrous aggregation increases the critical 
size of the nanoparticles in a solution and hence decreases the specific heat 
of the system. It is well reported that aggregation of nanoparticles decreases 
the SAR value significantly [170, 171]. Prevention of aggregation by BSA 
conjugation might have thus enhanced the SAR value of the system. As 
reported by Samanta et al in similar studies with SPIONs, this phenomenon 
could also be attributed to the increased colloidal stability of the BSA 
conjugated iron oxide nanoparticles. The BSA conjugated iron  oxide  
nanoparticles  were  well  separated  and  well suspended, even under applied 
magnetic field. Whereas the hydrophilic iron oxide nanoparticles without BSA 
conjugation aggregate in the presence of magnetic field. This interesting 
phenomenon of improved heating efficiency, relating to the colloidal stability 
imparted by the BSA to the iron oxide nanoparticles will be studied further. 
BSA conjugation over FIONs shows better SAR value than the BSA-SPIONS, 
due to the high saturation magnetization. Thus the second requisite for an 
efficient magnetic hyperthermia system is also well established.  






As schematic overview of the enhancement of biocompatibility and heating 
efficiency, combinatorially using BSA conjugation is shown in Fig. 3.15 
 
 
Fig. 3.15: Schematic overview of the BSA-FIONs to improve biocompatibility 
and heating efficiency. 
 
Magnetic hyperthermia treatment of BSA-Fe3O4 nanoparticles on tissue 
 
Since our results show that BSA-APTMS-FIONs can be potential candidates for a 
single combinatorial approach to enhance both the biocompatibility and heating 
efficiency. We studied the same on liver tissue. The AC magnetic field was 
adjusted so as to raise the temperature upto 45 ºC. It is clearly evident from Fig. 
3.16(a) that before the magnetic hyperthermia treatment, there is no tissue 






damage, as indicated by blue nuclei of live cells of the tissue. Magnetic 
hyperthermia treatment causes apoptosis (green cells) and further necrosis (pink 
nuclei) as shown in Fig. 3.16(b) 
 
 
Fig. 3.16: Magnetic hyperthermia treatment on liver tissue (a) liver tissue before 
magnetic hyperthermia treatment (b) liver tissue after magnetic hyperthermia 
treatment with 0.1 mg/mL BSA-APTMS-FIONs and 600 Oe AC magnetic field to 




Our preliminary work focuses on fabricating the optimum size Fe3O4 
nanoparticles without compromising on the heating efficiency and 
biocompatibility. We find that due to their higher magnetization of 87 emu/g and 
hence a SAR value of almost 1700 W/g irrespective of the surface modifiying 






agent used and a very good cell viability of almost 99%, 30 nm Fe3O4 
nanoparticles (FIONs) are promising candidates for magnetic hyperthermia. 
  
Fe3O4 nanoparticles of size 20 nm and different shapes were fabricated. 
nanopsheres were found to be uniform in size and shape distribution, though they 
have low heating efficiency. Spherical shape is widely considered to be lower in 
magnetization when compared to other shapes. The nanohexagons and 
nanotetragons fabricated gave a better SAR value of almost 1800 W/g, but the 
uniformity is under question. Therefore in this section we conclude nanospheres 
as better candidates due to their ease of synthesis and uniformity in size and 
shape.  
 
Varying the composition of Fe3O4 nanoparticles by replacing the Fe2+ ions with 
Co2+/ Ni2+ increases the surface anisotropy, thus increasing the SAR value even at 
the superparamagnetic regime. Thus 15 nm CoFe2O4 nanoparticles have a very 
high SAR value of almost 885 w/g than Fe3O4 nanoparticles of same size. Thus 
CoFe2O4 nanoparticles can be considered as potential candidates for magnetic 
hyperthermia application owing to their better SAR value. Though the biosafety 
of CoFe2O4 nanoparticles might not be as comparable as Fe3O4 nanoparticles, 
future works can be directed towards improving the biocompatibility of CoFe2O4 
nanoparticles. 
 






We have studied the biocompatibility and heating characteristics of both 
BSA-SPIONS and BSA-FIONs. BSA conjugation was done by both physical 
adsorption and strong covalent amide bond formation.  The haemolytic studies 
and cell viability studies discussed in this chapter confirm that the 
biocompatibility of the iron oxide nanoparticles increased after BSA conjugation. 
Particularly BSA-FIONs show better biocompatibility than that of BSA-SPIONs. 
The improved SAR value of the BSA conjugated iron oxide nanoparticles 
system is due to the enhanced colloidal stability and prevention of aggregation. 
Though the study of efficiency of the surface modifying agents used is 
beyond the scope of this chapter, we still report that BSA conjugation by 
covalent bonding using APTMS has better colloidal stability and hence better 
biocompatibility and heating efficiency, as BSA-APTMS-FIONs show better 
results than that of BSA-CTAB-FIONs. Also the higher magnetic saturation of 
FIONs lead to higher SAR value and hence better heating efficiency than 
SPIONs.  We thus conclude that the two key challenges of a very good 
magnetic hyperthermia system- improved biocompatibility and heating 
enhancement were addressed through the fabrication of BSA-FIONs. 
 











CHAPTER 4: Effects of Physiological Components and 



















Our previous chapters discussed the effect of magnetic hyperthermia on 
biosystem. Just as magnetic nanoparticles influence the physiology, the 
physiological components also have a significant impact on the biosystem. The 
pre-requisites for an efficient magnetic hyperthermia system are multitude, 
ranging from applied AC magnetic field, frequency, size and material properties 
of magnetic nanoparticles time dependent temperature exposure etc [172, 173]. 
Among these factors, applied AC magnetic field of radiofrequency 100-1000 kHz 
plays a significant role in influencing the heating efficiency of magnetic 
nanoparticles [174, 175]. The heating efficiency of magnetic hyperthermia is 
measured in terms of specific absorption rate (SAR). The SAR value of the 
magnetic nanoparticles is also found to increase with the AC magnetic field [176, 
177]. This raises serious concerns about biological safety under an applied AC 
magnetic field [178, 179]. In electrochemical therapy, under an applied electric 
field the chemical reactions between physiological ions causes cancer cell death 
due to change in chemical environment, pH and increase in temperature of the 
tumor site [180, 181]. Since physiological ions are found to be influenced by 
applied electric field, a better understanding of the effect of applied AC magnetic 
field of the magnetic hyperthermia system on the physiological ions is needed. 
Our previous studies have also indicated that surface modification of magnetic 






nanoparticles using surfactants of different surface charges contribute to 
temperature raise in magnetic hyperthermia due to better colloidal stability [182, 
183]. Though a systematic study on the effect of surface modification on 
magnetic hyperthermia is beyond the scope of this chapter, this further araises the 
question about contribution of surface charges or other physiological ions to 
heating efficiency. 
 
This chapter discusses the effect of physiological components under an applied 
AC magnetic field on heating efficiency and biosafety of magnetic hyperthermia 
system. Our results show that under an applied AC magnetic field of 600 Oe and 
frequency of 360 kHz, while the physiological electrolytes/ions contribute 
significantly to the heating efficiency of superparamagnetic iron oxide 
nanoparticles (SPIONs), the plasma proteins and cellular components tend to 
retard the temperature raise. Even without SPIONs, under an applied AC 
magnetic field, physiological ions increase the temperature raise and 
physiological proteins and cells retard the same. We understand that while heating 
efficiency of a magnetic hyperthermia system is increased by the physiological 
ions, the proteins present in the biosystem tend to mask the adverse temperature 
raise and radiation effects, thus acting as biosafety agents. We further confirmed 
these results by treating healthy kidney and liver tissue to AC magnetic field of 
600 Oe and frequency of 360 kHz, with and without SPIONs. The results show 






that AC magnetic field alone, without SPIONs does not cause any damage to the 
tissue, as proteins and cells insulate the heat dissipation under the exposed 
radiation. To our best knowledge, no previous attempts have been reported to 
systematically study the possible contribution of physiological ions, proteins and 
cells to magnetic hyperthermia. It is important to study the effect of physiological 
components on magnetic nanoparticles and their contribution to temperature raise 
under an AC magnetic field. This helps to develop a magnetic hyperthermia 





Magnetic hyperthermia experiments with superparamagnetic iron oxide 
nanoparticles in various media 
 
The hydrophilic SPIONs (0.1 mg/mL) were well suspended in water, 1xPBS, 
plasma (Sigma Aldrich), albumin solution, blood and other physiological fluids 
and used for our experiments. DLS measurements were made to confirm the size 
and stability of SPIONs in 1xPBS. Under an applied AC magnetic field of 600 
Oe, frequency 360 kHz and exposure time of 3 minutes, the temperature raise 
(ΔT) of SPIONs in the above mentioned media was studied. 






SAR is expressed as the heat released by the magnetic iron oxide 




Where, Cwat- specific heat of the medium (distilled water), 4.18 J /g/ ºC; ∆T/∆t- 
The initial slope of the time-dependent temperature curve; CFe- concentration of 
ferric i ons  in the medium, 0.1mg/mL. The concentration of ferric ions in the 
samples was determined using ICP-OES analysis (Perkin-Elmer Dual view 
Optima 5300 DV ICPOES system). The individual contribution of various 
physiological components without superparamagnetic iron oxide nanoparticles, 
towards temperature raise was studied under an applied AC magnetic field of 600 
Oe, frequency 360 kHz and exposure time of 3 minutes. 
 
Magnetic hyperthermia experiments and imaging with cells and tissue 
 
The MCF-7 cells suspended in 1xPBS were subjected to 0.1 mg/mL SPIONs and 
an applied AC magnetic field of 600 Oe (frequency 360 kHz), to bring a 
temperature raise (ΔT) of upto 42-45°C. The MCF-7 cells under AC magnetic 
field alone and after hyperthermia treatment were observed under confocal 
microscope (Olympus-FluoView, FV1000). The live MCF-7 cells were stained 






green with AlexaFluor 488 (Invitrogen) and nuclei of dead cells were stained red 
by Propidium Iodide (PI-ThermoFischer Scientific). 
 
The effect of application of AC magnetic field and the combination of AC 
magnetic field and 0.1 mg/mL SPIONs on healthy kidney and liver tissue were 
studied. The organs (kidney and liver) were treated with 0.1 mg/mL SPIONs and 
an applied AC magnetic field of 600 Oe (frequency 360 kHz), to bring a ΔT of 
upto 42°C-45°C. The healthy tissue before and after treatment were observed 
under confocal microscope (Olympus-FluoView, FV1000). Dyes NucBlue 
(ThermoFischer Scientific) to stain the total nuclei of cells, AlexaFluor 
(Invitrogen) to stain the apoptotic cells green and Propidium Iodide (PI-
ThermoFischer Scientific) to stain the nucleus of dead cells red were used to 
qualitatively visualize the excised organ tissue. While the nuclei of the live cells 
are stained blue, the nuclei of completely dead cells (necrosis) appear pink. 
Briefly, to 1 mm2of the excised tissue, 2 drops of NucBlue, 2.5 µL of AlexaFluor 
and 0.5 µL of PI were added along with 100 µL binding buffer and were 
incubated at room temperature for 15 minutes. The reaction was stopped by 
adding excess binding buffer and the samples were viewed under the confocal 
microscope. The images were later processed using the software IMARIS 8.0. 
Our preliminary studies are based on the qualitative observations of the stained 
cells/tissue morphology. 






4.3 Results and Discussion 
 
Synthesis of hydrophilic superparamagnetic iron oxide nanoparticles 
 
The heating efficiency of SPIONs in various physiological media was studied and 
are discussed in this paper. We had synthesized the SPIONs to be used in our 
studies. The size of the monodisperse, close-packed SPIONs was confirmed by 
the TEM micrographs in Fig. 4.1(a). The SAED pattern from Fig. 4.1(b) confirms 
the cubic spinel of the as-synthesized Fe3O4. The size of SPIONs was further 
confirmed from the XRD data using Scherrer’s formula. The diffraction peaks 
from Fig. 4.1(c) can be indexed as cubic spinel Fe3O4 (JCPDSno.19-0629), 
corresponding to (220), (311), (400), (422), (511) and (440). Broad peaks indicate 
that the particles are smaller in size. The magnetization saturation of the as-
synthesized SPIONs is found to be 45 emu/g as shown in Fig. 4.1(d). The 
hydrodynamic size of the CTAB-SPIONs was found to be 20±2 nm as shown in 
Fig. 4.1(e).  







Fig. 4.1: (a) TEM image of the as-synthesized SPIONs. Inset image is the high 
resolution TEM micrograph showing lattice; (b) TEM selected area electron 
diffraction image (SAED) of the SPIONs (c) XRD plot (d) Magnetization of the 
SPIONs (e) Average hydrodynamic radius of SPIONs in water. 






Heating efficiency of superparamagnetic iron oxide nanoparticles in 
physiological fluids 
 
As discussed earlier, SPIONs are potential candidates for magnetic 
hyperthermia. However, most hyperthermia studies for SPIONs are carried out 
in de-ionized water.  In this work, we have studied the hyperthermia effect of 
SPIONs in biological systems. The hydrophilic SPIONs were dispersed in de-
ionized water and the temperature raise (ΔT) was recorded. PBS of 1x 
concentration is widely used for biological studies to mimic the physiological 
electrolytes. Hence the same was used in our studies to represent physiological 
electrolytes. We studied the temperature raise (ΔT) due to hydrophilic SPIONs 
dispersed in 1x PBS. Furthermore any biological system is made of 
physiological fluids along with proteins and cellular components (which are 
also largely made of proteins). Since clinical applications involve the injection 
of SPIONs in blood before reaching the target site, we had studied the 
temperature raise (ΔT) of hydrophilic SPIONs in liquid tissue-blood. As 
shown in Fig. 4.2, 0.1 mg/mL hydrophilic SPIONs in de-ionised water raises 
the temperature upto 2.8°C within 3 minutes, corresponding to a SAR value of 
291 W/g (the value is well expected for SPIONs in water). In the second test, 
we dispersed 0.1 mg/mL SPIONs into 1xPBS. Temperature raise was around 
8.5°C within 3 minutes, which corresponds to a SAR value of 750 W/g for 0.1 
mg/mL SPIONs under the same conditions (600 Oe and 360 kHz).  






The result has shown that 1xPBS as the medium of dispersion for SPIONs can 
increase hyperthermia effect significantly. In the third test, 0.1 mg/mL 
SPIONs were dispersed blood.  The temperature raise was reduced to 2.6 °C, 
very similar to that when de-ionized water was used as the carrier. 
 
 
Fig. 4.2: Time dependent temperature raise (ΔT) of 0.1mg/ SPIONs in water, 
1×PBS and blood under 600 Oe at 360 kHz. Inset images are representational 
pictures of the samples. 
 
From Fig. 4.2, we observed that magnetic hyperthermia of SPIONs ticles can 
be enhanced greatly if the particles were dispersed in 1xPBS.Since our DLS 
measurements of SPIONs in 1xPBS showed that the particles were stable in 






1xPBS with a similar result as Fig. 4.1(e) (SPIONs in de-ionized water), the 
increase in heating efficiency might be attributed to the presence of ions in the  
physiological electrolytes (1xPBS). As shown in Fig. 4.2, SPIONs dispersed 
in blood tend to have comparable magnetic hyperthermia effect to SPIONs s in 
de-ionized water. It seems that the additional hyperthermia efficiency probably 
caused by the ions present was retarded by other components (such as cells 
and proteins). Thus, it is important to investigate how magnetic hyperthermia 
of SPIONs is affected in biological environment. This observation motivated 
us to further systematically study the contribution of individual physiological 
components towards hyperthermia under AC magnetic field. 
 
Contribution of physiological components to magnetic hyperthermia 
 
In this work, we have studied the contribution of individual physiological 
components towards to magnetic hyperthermia. All studies were carried out 
under the standard conditions of 600 Oe and 360 kHz for a period of 3 
minutes. 
 
Contribution of physiological ions to temperature raise 
 
Since 1xPBS can enhance magnetic hyperthermia as observed from Fig. 4.2, 
we carried out a series of experiments to further investigate if 1xPBS has 
hyperthermia properties. As shown in Fig. 4.3, the hyperthermia effect is 






clearly dependent on concentration of ions. The temperature raise (ΔT) 
decreased with decreasing PBS concentration. With 0.2xPBS, the temperature 
increase decreases to the level below 1°Cwhich is comparable with the 
measurement error (0.5 – 1.0 °C). 
 
Fig. 4.3: Effect of concentration of PBS on temperature raise (ΔT). As the 
concentration of 1x PBS increases, ΔT increases, indicating that concentration 
of ions to ΔT. 
 
In addition, we have studied how AC magnetic field affect the hyperthermia 
effect of 1xPBS. Magnetic field is found to affect the tissue in the presence of 
SPIONs. Therefore it is important to study the effect of magnetic field. 
Contribution of applied magnetic field over a range of 200-600 Oe and 
frequency at 360 kHz for 3 minutes were tested for 1x PBS without SPIONs. 






As shown in Fig. 4.4 as the magnetic field increases, the ∆T increases linearly 
in a proportionality equivalent to the square of applied field, (Applied field)2. 
  
 
Fig 4.4: Contribution of applied magnetic field towards temperature raise (ΔT) 
of 1x PBS  
 
The physiological composition of individual salts that constitute 1xPBS is 
shown in table 4.1. We have studied the hyperthermia effect of the individual 
constituent salts as shown in Fig. 4.5. It is also interesting to learn from the 
Fig. 4.5 that certain salts like potassium chloride (KCl) elicit higher 
temperature raise even at lower concentration of (0.05 M) when compared to a 
higher concentration of (0.1M) sodium chloride (NaCl). Fig. 4.5 also shows 






that the contribution of certain salts like dipotassium phosphate (K2HPO4) and 
disodium phosphate (Na2HPO4) is almost negligible after statistical error. 




Sodium Chloride (NaCl) 0.1 
Potassium Chloride (KCl) 0.05 






Sodium bicarbonate (NaHCO3 ) 0.04 
Calcium Chloride (CaCl2 ) 0.02 
Magnesium Sulphate (MgSO4) 0.005 











Fig. 4.5: Temperature raise (after 3 minutes under 600 Oe at 360 kHz) of 
individual salts that constitute 1xPBS. 
 
To further confirm that mobility of ions contribute positively to hyperthermia, 
we studied the effect of individual ions that make up 1xPBS. We had taken 
physiological sodium salts (sodium chloride, sodium sulfate, disodium 
hydrogen phosphate and sodium bicarbonate) of different concentration, viz 
0.1M, 0.5M and 1M. It is observed from Fig. 4.6(a) that as the degree of 
solvation increases, the contribution to temperature raise (ΔT) increases. The 
trend was maintained throughout increasing concentration of the salts. We also 
tried to study the contribution of different concentrations of physiological 
chloride salts (sodium chloride, potassium chloride and calcium chloride) to 
temperature raise (ΔT).  






From Fig. 4.6(b), we understood that as the size and atomic mass of the 
physiological salt increases, the contribution to temperature raise (ΔT) 
increases. This might be because of the higher oxidation state and atomic mass 
of the ions. The heavier ions generate more heat under the applied magnetic 
field. Also higher the ability to ions’ solvate and attract water molecules, 
higher is the heat generated. Thus ions contribute significantly towards the 
increase in heating efficiency of a magnetic hyperthermia system.  
 
Fig. 4.6: Contribution of individual ions (a) sodium salts (b) chloride salts to 
temperature raise (ΔT) 
 
Further studies on the effect of physiological acids and ions on temperature 
raise were carried out. pH plays a pivotal role in cancer biology, both in the 
intra and extracellular regimes [184, 185]. Physiological acids like lactic acid 
which are secreted because of anaerobic respiration of cancerous cells 
sensitize the tumor cells to heat treatment [186, 187].  We wanted to study if 
acids, in physiologically feasible concentration of around 0.1M and pH value 






of 5.4-5.7 can be sole or synergistic heating agents under applied magnetic 
field for magnetic nanoparticle based hyperthermia. Fig. 4.7 shows that the 
cellular acids, in near physiological concentrations contribute a little to heating 
characteristics. Citric acid contributes to ∆T as low as 2.2°C, followed by 
acetic acid 2.38°C, ascorbic acid 2.5°C and lactic acid 2.7°C. Physiological 
acids are secreted more by cancerous tissue and have been reported to 
contribute towards the sensitization of tumor cells. 
 
For comparison studies, we also studied the contribution of 0.1 M strong 
acids. Hydrochloric acid leads to higher temperature raise (∆T) of 4.5°C, 
followed by nitric acid 3.8°C and sulphuric acid 3.2°C. The purpose of this 
study is to understand that as the dissociation constant (ka) increases (weak 
acids to strong acids), the contribution of the acids to the temperature raise 
(ΔT) increases. The strength of any acid in a solution is quantitatively 
expressed as dissociation constant (ka). Weak acids have low dissociation 
constant as their extent of dissociation into constituent components is low. The 
logrithamic constant of dissociation constant (ka) is expressed as pka and is the 
inverse of ka. We understand from Fig. 4.7, that as the pka decreases, the ∆T 
increases as the mobility of ions in the solution increases and causes a 
temperature raise (∆T).
 







Fig. 4.7: Contribution due to acids to temperature raise (ΔT). The temperature 
raise (ΔT) is proportional to the dissociation constant (ka) of the acids. 
 
In this work, we have studied hyperthermia attributed to the presence of ions.  
Our study has shown that hyperthermia effect (or temperature raise, ΔT) 
strongly depends on magnetic field and concentration, as well as dissociation 












Contribution of physiological proteins to temperature raise 
 
The above study has shown that the presence of ions can contribute to 
hyperthermia under AC magnetic field at radio-frequency range. As shown in 
Fig. 4.2, the contribution of ions to hyperthermia can be greatly reduced in 
blood. This observation motivated us to investigate the mechanism(s) behind 
the decreased heating efficiency of SPIONs in blood. We can simplify blood 
to be an amalgamation of physiological electrolytes, proteins and cells [188, 
189]. Therefore along with the study on contribution of ions, a better 
understanding of the contribution of proteins and cells towards temperature 
raise (ΔT) is also important. Since in our previous sections we have already 
reported the heating efficiency of SPIONs in physiological electrolytes and 
individual contribution of ions, in this section we have attempted to study the 
heating efficiency of SPIONs in blood and the individual contribution of the 
blood components towards temperature raise (ΔT) without SPIONs. In 
addition, blood has higher viscosity compared to 1xPBS and ionized water.  
 
Our first study is to understand if viscosity can affect greatly the hyperthermia 
effect of ions. Inorder to understand the contribution of viscosity towards 
retardation of temperature raise (ΔT), we simulated a viscous environment by 
the addition of 50mg/mL agarose in 1xPBS. Agarose was chosen for our 
viscosity studies as it is a neutral polymer and a common gelating agent [190, 
191]. As shown in Fig. 4.8, the addition of agarose doesn’t change the heating 






curve significantly, showing that the hyperthermia effect due to ions is not 
strongly dependent on viscosity. Our previous results also indicate that 
SPIONs in agarose gel does not change the temperature raise (ΔT) [192]. 
 
 
Fig. 4.8: Temperature raise in dependence of time for 1xPBS and 1xPBS with 
50 mg/ML agarose under AC magnetic field of 600 Oe at 360 kHz. 
 
Since viscosity doesn’t significantly affect the heating characteristics, we then 
attempted to study the other mechanisms by which the blood components 
might affect the temperature raise (ΔT). We further studied in the detail the 






role of proteins towards retardation of temperature raise (ΔT) since blood is 
made of physiological electrolytes (of 1xPBS concentration), proteins and 
cells. Our first study was the hyperthermia effect of plasma (which might be 
considered as a biofluid with a composition similar to that of protein in 
1xPBS). Indeed, the hyperthermia effect has been significantly reduced with 
or without magnetic nanoparticles compared to its counterpart–1xPBS. 
Without magnetic nanoparticles, temperature raise (ΔT) was found to be 5.5 
°C for 1xPBS under the standard condition (600 Oe at 360 KHz for 3 
minutes), while temperature raise (ΔT) was significantly reduced to 2.2 °C for 
plasma under the same condition. 
 
The further study was hyperthermia effect of 1xPBS with different 
concentration of protein. We chose the most abundant plasma protein- 
albumin for our studies. The total albumin concentration in blood plasma is 
50mg/mL albumin [193, 194]. The total protein content of plasma is 
80mg/mL, including albumin and globulin [195]. From Fig. 4.9(a), it is 
observed that as the concentration of albumin in 1xPBS increases, the 
temperature raise (ΔT) decreases. For albumin concentration of 50mg/mL in 
1xPBS, temperature raise (ΔT) decreases to 2.4°C. When the concentration 
increases to 80 mg/mL, temperature raise (ΔT) further retards to 2°C. It should 
be noted that this value is almost as the same as temperature raise (ΔT) 2.2°C 
for plasma (which also contents a total protein concentration of 80 mg/mL). 
The addition of SPIONs in the simulated protein environment (in 1xPBS) 






follows the trend. The heating efficiency of SPIONs in 80mg/mL protein 
environment is 3.4°C, which is comparable to that in plasma (3.2°C). 
Similarly, SPIONs in 100mg/mL protein environment (in 1xPBS) shows a 
decreased temperature raise (ΔT) of only 2.8°C, which is the same SPIONs in 
pure ionized water (2.6°C). As shown in Fig. 4.9(a), even under 100 mg/mL of 
albumin in 1xPBS, there is still clear temperature of 1.7 °C. But for pure 
blood, no noticeable temperature raise (ΔT) was measured. The result 
indicates that cells should have certain reducing effect on hyperthermia. 
Therefore we studied the contribution of 1xPBS and cells. We used MCF-7 
cells for our studies. In our studies, for ease of understanding, we consider 
cells to be proteins as well, since cells are made of 55% proteins [196]. Fig. 
4.9(b) shows that MCF-7 cells suspended in 1xPBS without SPIONs does not 
cause temperature raise (ΔT) and hence the MCF-7 cells are alive (stained 
green) under an applied AC magnetic field of 600 Oe and frequency of 360 
kHz. But in the presence of 0.1 mg/mL SPIONs, under an applied AC field, 
the temperature of MCF-7 cells suspended in 1xPBS increases upto a 
therapeutic window of 45°C and thus causing the death of MCF-7 cells (red 
nuclei). These studies further confirm that proteins play a role in masking the 
effect of physiological ions. 
 







Fig. 4.9: Temperature raise due to physiological protein albumin (a) 
Temperature raise (T) as a function of albumin concentration in 1xPBS 
under 600 Oe at 360 kHz for 3 minutes with and without SPIONs (b) 
Hyperthermia effect on cells suspended in 1xPBS without SPIONs under an 
applied AC magnetic field–MCF-7 cells are alive as indicated by the green 
cells in the corresponding confocal image; Hyperthermia effect on cells 
suspended in 1xPBS with SPION under an applied AC magnetic field-  MCF-
7 cells are dead as indicated by the red nuclei in the corresponding confocal 
image.  






Mechanism of action of physiological components (ions and proteins) on 
magnetic hyperthermia 
 
In this work, we have observed that physiological ions can contribute 
positively to hyperthermia. We have noted that temperature raise (ΔT) 
depends on several factors, such as concentration, dissociation (or solvation) 
and atomic mass/size. The results suggest that hyperthermia might be 
attributed to ionic conduction due to mobility under an applied AC magnetic 
field. The plausible mechanism by which proteins, especially plasma proteins 
retard the effect of ions could be by restricting their mobility. The antagonistic 
behaviour of physiological ions and proteins can be explained through ion 
mobility and protein surface charge and structure. Ions are trapped in the 
protein structure and are unavailable to vibrate and generate heat under 
applied magnetic field. Moreover albumin is a dipolar molecule with excess 
cations (amino groups) and anions (carboxyl groups) on its surface, which 
attract the corresponding oppositely charged ions from the physiological 
electrolytes and further makes them unavailable for heating [197]. This is one 
reason for decrease in heating efficiency by the plasma proteins. Thus 
physiological proteins act as biological safety agents that mask the adverse 
effect of magnetic hyperthermia of SPIONs on the animal/human biosystem. 
Fig. 4.10 shows the mechanism of ionic mobility in physiological electrolytes 
and protein environment.  







Fig. 4.10: Mechanism of action of physiological components towards 
magnetic hyperthermia. Salt solution comprising of cations and anions under 
an applied electric field move towards cathode and anode respectively 
increasing the temperature raise (ΔT). Whereas the addition of protein with 
surface charges due to cationic amino (NH2+) groups and anionic carboxyl 
(COO-) groups trap anions and cations respectively and retard their mobility 










Electrochemical studies were conducted to support our proposed mechanism 
that mobility of ions is a contributing factor for heating efficacy and proteins 
retard the same. Distilled water, 0.1M sodium chloride solution, 50 mg/mL 
albumin in distilled water were prepared and impedance was studied over a 
frequency range of 100 Hz to 1000 kHz. Our experimental frequencies of 150 
kHz, 360 kHz and 488 kHz lie within this broad frequency range.   
 
As seen from Fig. 4.11(a) de-ionised water has the highest impedance showing 
that there is almost no conductance. Fig. 4.11(b), the impedance of 50 mg/mL 
albumin in distilled water is around 620 Ω in the frequency range used in our 
magnetic hyperthermia experiments. This shows that proteins are charged 
biomolecules and hence have reduced impedance. Fig. 4.11(c) shows the 
comparison between the real parts of impedance of de-ionised water and 
albumin in water. From Fig. 4.11(d) we observe that 0.1M sodium chloride 
(NaCl) in de-ionised water has an impedance of only 5Ω in the frequency 
range used in our magnetic hyperthermia experiments. Thus substantiating the 
fact that addition of ions increases the conductivity. From Fig. 4.11(d) we also 
observe that a solution of 0.1M sodium chloride (NaCl) and 50 mg/mL 
abumin in de-ionised water has an impedance of only 40 Ω in the frequency 
range used in our magnetic hyperthermia experiments. While this shows the 
conductance of ions, it also shows that protein molecules can trap the mobile 
ions and retard their mobility hindering their contribution towards 
conductivity. The results of electrochemical studies are in unison with the 






magnetic hyperthermia studies. This supports our proposed mechanism of 
temperature raise (ΔT) contribution of ions and proteins 
 
Fig. 4.11:  Impedance of (a) de-ionised water (b) 50 mg/mL albumin in de-
ionised water (c) comparison between real parts of de-ionised water and 50 
mg/mL albumin in de-ionised water (d) comparison between 0.1 M NaCl in 
de-ionised water and solution of 0.1 M NaCl-50 mg/mL albumin in de-ionised 
water. 
 
Thus it can be deciphered that proteins and cells are an inherent biological 
safety mechanism to prevent the adverse effect of heat dissipation under the 
radiation exposure used for biomedical applications. Inorder to confirm the 
same, we studied the effect of applied AC magnetic field on healthy tissue.  






Effect of magnetic hyperthermia on healthy tissue 
 
From the above studies, we understand that the use of AC magnetic field is 
safe for biological system in terms of thermal effect. This is due to the 
presence of proteins and cells (which are made predominantly of proteins) that 
can prevent temperature raise (ΔT) caused by physiological ions. The 
biologically safe standards of maximum field, frequency and/or field 
frequency have been proposed [198].  In order to verify the biosafety under 
AC magnetic field, we have studied cells before and after application of AC 
field in comparison with cell damage after thermal effect. Liver and kidney 
tissue excised from male Wistar rats were used in this study under the standard 
condition of 600 Oe and 360 kHz. Magnetic hyperthermia treatment under the 
combined effect of applied AC magnetic field and 0.1mg/mL SPIONs 
increases the temperature upto a therapeutic window of 42-45°C leading to 
severe apoptosis and necrosis, as widely considered. Inorder to confirm the 
same, we carried out magnetic hyperthermia experiments on liver and kidney 
tissue. Fig. 4.12 shows effect of magnetic hyperthermia on healthy liver tissue. 
Fig. 4.12(a) represents healthy liver tissue as well as tissue after exposure of 
600 Oe AC magnetic field for 3 minutes. From the confocal blue nuclei 
indicating lives cells are observed. These qualitative results indicate that AC 
magnetic field alone without SPIONs does not elicit damage of healthy tissue 
though physiological ions actually contribute towards heating.  
 






This result supports that cellular proteins act as biosafety agents which prevent 
damage of healthy tissue. Whereas the combined application of AC magnetic 
field of 600 Oe and 360 kHz and 0.1 mg/mL SPIONs causes tissue apoptosis 
(green cells) and necrosis (pink nuclei of dead cells) as seen from Fig. 4.12(b). 
We repeated the experimental set-up on kidney tissue to further confirm the 
same. Fig. 4.12(c) represents both the healthy kidney tissue and tissue after 
application of AC magnetic field of 600 Oe alone for 3 minutes, both which 
have live cells (blue nuclei). Whereas the addition of 0.1 mg/mL SPIONs 
under the AC magnetic field raises the temperature upto 42-45°C causing cell 
necrosis (pink nuclei) as shown in Fig. 4.12(d). This further proves that AC 
magnetic field alone does not elicit tissue damage and are well within 
biosafety standards and supports our results with liver tissue. Our results are 
unison with the widely accepted concept of magnetic hyperthermia, wherein, 
temperature raise due to magnetic nanoparticles under an applied magnetic 
field, causes cell necrosis [199].  







Fig. 4.12: Magnetic hyperthermia effect on liver tissue (a) Healthy liver 
tissue/tissue after exposure to AC magnetic field of 600 Oe without SPIONs 
has live cells (b) liver tissue after magnetic hyperthermia treatment under AC 
magnetic field and 0.1 mg/mL SPIONs causes tissue necrosis and apoptotic 
cells (c) Healthy kidney tissue/ tissue after application of AC magnetic field 
alone without SPIONs has live cells (d) liver tissue after magnetic 
hyperthermia treatment under AC magnetic field and 0.1 mg/mL SPIONs 










We further wanted to confirm that the tissue damage was due to hyperthermia 
induced by SPIONs and not any other physical parameter like applied AC 
magnetic field. Hence we adjusted the magnetic field and frequency so as to 
cause a temperature raise (ΔT) of 42°C and 45°C. The results are shown in 
Fig. 4.13.  Fig. 4.13(a) shows healthy liver tissue with live cells (blue nuclei). 
Fig. 4.13(b) shows that the temperature raise of upto 42°C causes apoptosis 
(green tissue) and Fig. 4.13(c) shows that 45°C causes complete cell death 
(pink nuclei).  
 
 
Fig 4.13: Temperature effect on liver tissue (a) healthy liver tissue with live 
cells (b) temperature raise (ΔT) of upto 42°C causes apoptotis (c) temperature 
raise (ΔT) of upto 45°C causes complete necrosis  
 
Thus our studies show that AC magnetic field does not render any significant 
damage to healthy tissue. The biosafety of AC magnetic field is also enhanced 
by physiological proteins, for reasons discussed in the previous sections.  
 








We have studied the effect of physiological components (ions and proteins) on 
the heating efficiency (interms of ΔT and SAR value) of magnetic 
hyperthermia system. We have systematically studied the individual effect of 
each component on the heating efficacy of SPIONs under an applied AC 
magnetic field and also their individual contribution to ΔT. Our results 
indicate that physiological ions contribute positively towards the heating 
efficacy of magnetic hyperthermia system due the mobility and diffusivity of  
the ions. Whereas physiological proteins significantly retard the temperature 
raise of the SPIONs under an applied AC magnetic field. Therefore the overall 
contribution heating efficiency is decreased. Thus physiological proteins and 
cells provide intrinsic biosafety to the biosystem from adverse temperature 
raise due to exposure to applied AC magnetic field in magnetic hyperthermia. 
Our studies further confirm that applied AC magnetic field alone does not 
damage the healthy tissue since physiological proteins and contribute towards 
biological safety. While extensive research is going on to improve the 
biocompatibility and heating efficiency of the magnetic nanoparticles, a better 
understanding of contribution of physiology components towards heating 
efficacy and biosafety is very important. Our study intends to provide a simple 
reference to the effect of physiological components on magnetic nanoparticles 
under an applied AC magnetic field.  
 





































This thesis focuses on the synthesis and biomedical application of magnetic 
metal oxide (Fe3O4, Gd2O3) nanoparticles. Since our previous chapters have 
extensively discussed the fabrication and magnetic hyperthermia application 
of Fe3O4nanoparticles. This chapter focuses on the fabrication and application 
of Gd2O3 nanoparticles in MRI. As discussed earlier, magnetic resonance 
imaging (MRI) is a promising imagingtechnique for disease diagnosis at an 
early stage. It provides highspatial resolution and fine anatomical detailing 
without exposure to radioisotopes and hence is a complementarymodality for 
molecular imaging [200, 201]. Contrastagents are injected  to distinguish  the 
hydrogen nuclei situatedat varied environment and highlight the site of interest 
due to  contrast difference resulting from the alternation of the signalintensity 
[202, 203]. Gadolinium possesses seven unpaired electrons witha spin that 
perturbs the proton relaxation inwater,  resulting in an efficientshortening of 
longitudinal relaxation time (T1) and increase in themagnetic resonance signal 
intensity. Hence, gadolinium based image contrast agents provide positive 
signals, attracting wide researchinterest [204, 205]. Gadolinium based image 
contrast agents are the widely used contrast agents in MRI [206]. The 
unbounded gadolinium ions areknown to inhibit the calcium channels leading 
to considerable cardiovascularand neurologic toxicity [207, 208]. The toxicity 
can besignificantly reduced when the gadolinium ions are chelated [209]. 
However, the concern of the toxicity of gadolinium chelates persists as they 
release smallamount of free gadolinium ions. Inorganic crystalline gadolinium 
based compound nanoparticlesprovide a fixed crystal environment effectively  





prevents nanoparticles from leaking free gadolinium ions and hence are 
considered to be new generation of T1 contrast agents [210, 211]. It is a well 
accepted fact that only surface gadoliniumclose to the surface contributes to 
the contrast effect. Therefore, the uniform size and large surface area is very 
important. Thermal decomposition method gives hydrophobic oleic acid 
capped Gd2O3nanoparticles. The influence of different surface modifying 
agents on Gd2O3 nanoparticles is investigated in this chapter, based on their 
T1 relaxation time.  
 
Our previous attempts to find a good biocompatible surface modifying agent 
shows that albumin conjugation improves the biocompatibility significantly. 
We expect Gd2O3 nanoparticles conjugated with albumin to have better blood 
circulation time, without compromising on the biosafety. This is an important 
factor to be considered for clinical MRI imaging.  At the same time, since we 
are aware of the long folded chain structure of Bovine Serum Albumin (BSA), 
which might make it difficult for the availability of surface gadolinium, we 
also tried to cap the Gd2O3 nanoparticles thioglycolic acid. Since thioglycolic 
acid (TA) is a very small molecule available to be readily exchanged with 
oleic acid, it renders hydrophilicity to the Gd2O3 nanoparticles, without 
compromising on the availability of surface gadolinium. This section explores 









Later we also tried coating the as-synthesized Gd2O3 nanoparticles with a 
neutral polymer polyvinyl pyrrolidone(PVP) using a ligand exchange strategy. 
Since PVP offers a neutral surface and inorganic surface, it does not elicit the 
attraction of unwanted charged molecules. Therefore in this section we tried to 
cap the Gd2O3 nanoparticles with long chain PVP of 40, 000molecular weight. 
Later we photodegraded the PVP chains in-situ. We expected to achieve better 
relaxivity of short chain PVP chains, due to easy accessibility to water.  Due to 
the high surface energy of theultra-small Gd2O3 nanoparticles, aggregation or 
dissociation always occurred during the ligand exchange process in 
harshchemical synthesis environment [212]. However, the ligand 
exchangewith PVP was very successful in our situation. Excessive PVPwas 
used in the reaction as a driving force for ligand exchange. Dichloromethane 
assisted the precipitation of PVP coated Gd2O3 nanoparticlesin ethyl ether 




Haemolytic studies  
 
Erythrocytes were collected by centrifuging the blood of 5 weeks old SCID 
mice at 700 rpm. The pellet was re-suspended in saline at a ratio of 1:4. The 
test samples-  as-synthesized Gd2O3 nanoparticles, TA/PVP capped Gd2O3 
nanoparticles and BSA conjugated Gd2O3 nanoparticles, each o f Gd3+ ion 
concentration 0.5 mg/mL were added to the erythrocytes and the samples were  





incubated at 37ºC for 2 hours. Distilled water, which leads to 100% lysis was 
used as the positive control as it causes complete haemolysis due to osmosis. 
0.1M NaCl was used as negative control, as it is isotonic with the intracellular 
solute concentration. Haemolysis of erythrocytes is due to the oxidative stress 
caused by the test samples on the erythrocytes. The stress ruptures the cell 
membrane of the erythrocytes and hence the haemoglobin (Hb) leaks out into 
the solution. The absorbance of the leaked haemoglobin was measured at 540 
nm by UV–Vis spectrophotometer (UV-Vis, ShimadzuUV-1601). % 
Haemolysis can be calculated using the formula, 
%Haemolysis= [At-An/Ac-An]x100 
Where, At- absorbance of thetestsample at 540 nm; An- absorbance of the 
negative control (0.1M NaCl) at 540 nm; Ac-absorbance of the positive control 
(distilled water) at 540 nm. The haemolytic index was also calculated 
according to ASTMF756-00 standards, according to which, 0-2 % is non-
haemolytic; 2-5% is mildly haemolytic and >5% is haemolytic. 
 
Cell viability studies 
 
The BHK cells suspended in 1xPBS were co-incubated with 100 µg/mL of 
TA/PVP capped and BSA conjugated Gd2O3 nanoparticlesfor 24 hours at 
37°C. The BHK cells after incubation were run under flow cyclometry. Dyes 
NucBlue (ThermoFischer Scientific) to stain the total nuclei of cells, 
AlexaFluor (Invitrogen) to stain the apoptotic cells green and Propidium  





Iodide (PI-ThermoFischer Scientific) to stain the nucleus of dead cells red 
were used to qualitatively visualize the cells.  Briefly, to 1 mm2of the BHK 
cells, 2 drops of NucBlue, 2.5 µL of AlexaFluor and 0.5 µL of PI were added 
along with 100 µL binding buffer and were incubated at room temperature for 
15 minutes. The reaction was stopped by adding excess binding buffer and the 
samples were run in flow cytometry. In the histogram comprises of 4 
quadrants. Quadrant 1 (Q1) represents cells that have under gone complete 
necrosis; Quadrant 2 (Q2) represents cells at late stage apoptosis, wherein the 
cell membrane has ruptured; Quadrant 3 (Q3) represents cells at early stage 
apoptosis; Quadrant 4 (Q4) represents live cells. 
 
Relaxivity measurements  
 
Gd2O3 nanoparticleswere fabricated and made hydrophilic by TA/PVP 
capping  and biocompatible by conjugating with BSA. The samples were well 
dispersed and stable in water. The highest concentration of Gd3+ ions in the 
samples were 0.3mM each. The samples were diluted to 6 different 
concentrations (0.3mM, 0.15 mM, 0.075 mM, 0.037 mM 0.018 mM and 0 
mM). The longitudinal (r1) and transverse (r2) relaxivities were measured 
using a 7TBrukerClinScan with a Siemens interface and 72mmvolume coil. 
T1 measurement was done using an inversion-recovery sequence; TR/TE = 
5000/7; Average=3; flipangle = 90° and inversion-times (TIs) =31, 150, 300, 
700, 1200, 1800, 2400, 3000,3600, 4000, 4500 and 4900 ms. T1 was 
calculated from the inversion-recoveryimages, by fitting for the decay curve.  





T2 measurement was performed using a multiple spin echosequence TR = 
5000 ms; TE = 12.9; NE = 14. The sample was maintained at 36°Cusing a 
water bath. T2 maps were obtained along with the inline acquisitionsequence 
program. The r1 and r2 values were obtained fromslope of the linear fit 
between 1/T1 or 1/T2 vs concentration of contrast agent in mM. The relaxivity 
is represented as mM-1s-1 ± SD (n = 3). 
 
5.3 Results and Discussion 
 
As-synthesized Gd2O3 nanoparticles 
 
Ultra-small Gd2O3 nanoparticlesof size 3±1 nm was synthesized by thermal 
decomposition method. Fig 5.1(a) shows the TEM image of the as-synthesized 
oleic acid capped Gd2O3 nanoparticles. The particles seem to be aligned in 
chains. This might be due to the high surface energy of the ultra smallGd2O3 
nanoparticles.The SAED pattern corresponding to (222), (440) and (664) in 















Fig. 5.1: As-synthesized hydrophobic, oleic acid capped Gd2O3 nanoparticles 




5.3.1 Comparison between thioglycolic acid and BSA conjugated Gd2O3 
Nanoparticles 
 
Hydrophilic phase transfer of Gd2O3 nanoparticles using TA and BSA 
 
Since the as-synthesized Gd2O3 nanoparticles were hydrophobic in nature due 
to oleic acid coating, they were converted to water phase by ligand exchange 
with TA. Later the TA capped Gd2O3 nanoparticles were converted to 
biocompatible phase by conjugating withBSA. Fig. 5.2 shows the 
hydrodynamic radius comparison between TA capped Gd2O3 nanoparticlesand 
BSA conjugated Gd2O3 nanoparticles. As expected, BSA conjugated Gd2O3  





nanoparticles have much higher average hydrodynamic radius of 16±2 nm 
than 7±2 nm of their TA counter part.The inset figure shows the TEM image 
of BSA conjugated Gd2O3 nanoparticles. 
 
 
Fig. 5.2: Average hydrodynamic radius of BSA conjugated Gd2O3 
nanoparticles. Inset image shows the TEM image of BSA conjugated Gd2O3 
nanoparticles. 
 
Biocompatibility of TA capped and BSA conjugated Gd2O3 nanoparticles 
 
The haemolysis studies confirm that blood compatibility of BSA conjugated 
Gd2O3 nanoparticles. Fig. 5.3(a) shows that BSA conjugated Gd2O3 
nanoparticles have a very low haemolysis of 1.2 % (non-haemolytic) when  
 




compared to 4.8 % of TA capped Gd2O3 nanoparticles (mildly haemolytic) 
and 52.3 % of oleic acid capped Gd2O3 nanoparticles (haemolytic).The inset 
photos show the Oleic acid (OA) capped, Thioglycolic acid (TA) capped and 
BSA conjugated Gd2O3 nanoparticles.We hence performed the cell viability 
studies on healthy BHK cells. The histogram in Fig. 5.3(b) and Fig. 5.3(c) 
shows that TA capped Gd2O3 nanoparticles (98.4%) are less viable than BSA 
conjugated Gd2O3 nanoparticles (99.6%), as BSA is a better biocompatible 
agent. It should be noted that there are almost no cells in Q1 and Q2, 
indicating that there no healthy BHK cells entering necrosis or even late stage 
apoptosis respectively. TA capping does not completely render biosafety, 
owing to their small size, exposing the gadolinium to the biosystem.  Quadrant 
Q1 of Fig. 5.3(b) shows cells indicating that some cells have entered into 
necrosis, while Q2 shows that there are a few cells in late apoptotic stage. 
 





Fig. 5.3: Biocompatibility of BSA conjugated Gd2O3 nanoparticles a) 
Haemolytic study comparison between oleic ccid (OA) capped, thioglycolic 
acid (TA) capped and BSA conjugated Gd2O3 nanoparticles. Inset image 
shows the haemolysed blood sample b) Cell viability of TA capped Gd2O3 
nanoparticles- 98.4% c) Cell viability of TA capped Gd2O3 nanoparticles- 
99.6% 
 
Relaxivity measurements of TA capped and BSA conjugated Gd2O3 
nanoparticles 
 
As shown in Fig. 5. 4(a) TA capped Gd2O3 nanoparticles show a high r1 value 
of 3.3 mM-1s-1 when compared to the r1 value of 2.8 mM-1s-1 of BSA 
conjugatedGd2O3 nanoparticles as shown in Fig. 5.4(b). It is to be noted that 




for a concentration of Gd3+ as low as 0.3 mM, a very good relaxivity is 
achieved. This is due to the easy access of surface gadolinium to water 
molecules. The inset T1 phantom images of TA capped Gd2O3 nanoparticles 
and BSA conjugated Gd2O3 nanoparticles at different concentrations clearly 
demonstrated their contrast difference as T1 contrastagents.  
 
 
Fig. 5.4: Relaxivity measurements a) TA capped Gd2O3 nanoparticlesb) BSA 
conjugated Gd2O3 nanoparticles. 
 
5.3.2 In-situ Photodegraded Poly Vinyl Pyrrolidone coated Gd2O3 
nanoparticles 
 
Hydrophilic phase transfer of Gd2O3 nanoparticles by in-situ 
photodegraded PVP coating 
 
Ultra-small Gd2O3 nanoparticlesof size 3±1 nm as discussed in the previous 
section was used for in-situ photodegradion of PVP coated Gd2O3 




nanoparticles. The as-synthesized particles were hydrophobic in nature, and 
were converted to water phase by ligand exchange of oleic acid moiety with 
40,000 MW PVP.  Fig. 5.5(a) shows the FTIR plot for PVP capped Gd2O3 
nanoparticles.The resonance peaks in the plot at 1643 1/cm corrsponding to 
C=O and 1415 1/cm corresponding to C-N indicate the presence of PVP and 
the disappear of two characteristic bands at 1557 and 1443 1/cm 
corresponding to the antisymmetric (COO_), and the symmetric, (COO_), 
stretches confirms the complete removal of oleic acid. The samples were then 
photodegraded using UV lamp of 300 Watt. Fig. 5.5(b) shows the average 
hydrodynamic radius PVP capped of Gd2O3 nanoparticles, at 0th hour, 1 hour, 
2 hours, 3 hours and 4 hours. There is a clear decrease in the average 
hydrodynamic radius, thus confirming that photodegradation has happened.  
 
 
Fig. 5.5: Hydrophilic phase transfer of photodegraded PVP coated Gd2O3 
nanoparticles a) FTIR plot of photodegraded PVP coated Gd2O3 nanoparticles 
b) average hydrodynamic radius of photodegraded PVP coated Gd2O3 
nanoparticles. 
 




Biocompatibility studies of photodegraded PVP coated Gd2O3 
nanoparticles 
 
Fig. 5.6 shows the cell viability histogram of photodegraded PVP coated 
Gd2O3 nanoparticles on healthy BHK cells. The cell viability is upto 99%, 
without much cells in quadrants Q1. This indicates that the cells did not enter 
into necrosis stage, even after incubation for 24 hours. This shows that the 
photodegraded PVP coated Gd2O3 nanoparticles show better biocompatibility 
and are as good as organic, BSA conjugated Gd2O3 nanoparticles. The inset 
imade shows that there is the sample non-haemolytic, upto 1.2 %. 
 
Fig. 5.6: Biocompatibility of photodegraded PVP coated Gd2O3 nanoparticles, 
showing cell viability of 99% and haemolysis of 1.2%. 
 
 




Relaxivity measurements photodegraded PVP coated Gd2O3 
nanoparticles 
 
Fig. 5.7 shows that the r1 (12.3 mM-1s-1) and r2 (17.6 mM-1s-1) values for 
photodegraded PVP capped Gd2O3 nanoparticles were much higher than that 
discussed in our previous section. The inset image gives the T1 phantom 
images corresponding to various concentrations. The polar C=O group in each 
monomer of PVP also allows the water molecules to pass throughthe coating 
layer and hence facilitates the  interaction  with Gd2O3 nanoparticleswhich 
further  reduces the T1 relaxation time. In-situ photodegradation is better than 
using short chain PVP of 5000 MW. This is because, in-situ photodegradation 
gives the convenience of manipulating the length of the PVP chain, as per our 
requirements. Chain lengths as low as 3 nm capping the gadolinium 
nanoparticles individually, without compromising on the biocompatibility can 
be achieved. This is not possible with commercially available long chain PVP. 
In-situ photodegradation is better than pre-photodegradation before capping, 
because, it makes use of the strong ligand exchange capabilities of long chain 
PVP. Thus ensuring better surface modification. The excess oleates and 


















We have fabricated surface modified Gd2O3 nanoparticles. Our results show 
that while long chain BSA conjugated Gd2O3 nanoparticlesrender better 
biocompatibility of upto 99.6% cell viability and 1.2% haemolysis, TA capped 
Gd2O3 nanoparticlesgive better MR contrast of r1 value 3.3 mM-1s-1due to the 
easy availability of surface gadolinium. The values are almost as good as 
commercially available MRI contrast agents. BSA conjugated Gd2O3  
 
 




nanoparticles can be further manipulated to enhance the relaxivity so as to 
serve as a good organic image contrast agent.  
 
In later part of our studies, we coated the as-synthesized Gd2O3 nanoparticles 
with in-situ photodegraded PVP. This gave better r1 relaxivity of 12.3 mM-1s-
1
. Since PVP coating has shown good biocompatibility in our previous studies, 
breaking the polymer chain in-situ gives a better edge to it, as it reduces the T1 
relaxation time. The photodegraded PVP coated Gd2O3 nanoparticles have a 
cell viability upto 99%. 













CHAPTER 6: Fe3O4-Gd2O3 Nanoclusters for Magnetic 

















Our previous chapters have discussed the potential application of iron oxide 
(Fe3O4) nanoparticles in magnetic hyperthermia based cancer therapy and 
gadolinium oxide (Gd2O3) nanoparticles for MR imaging. In this chapter we 
tried to combine the advantages of both the metal oxide nanoparticles to get a 
combinatorial edge of the same for a theranostic approach. Therefore we have 
synthesized iron oxide- gadolinium oxide (Fe3O4-Gd2O3) nanoclusters inorder 
to enhance the T1 and T2 relaxivity for better MR imaging and also explore 
the magnetic hyperthermia properties of the same.  
 
As discussed extensively in previous chapters, iron oxide (Fe3O4) 
nanoparticles have been used as useful platform material for multitude of 
biomedical applications like magnetic drug targeting, biomolecule separation, 
and hyperthermal cancer therapy [214, 215]. Also gadolinium oxide (Gd2O3) 
nanoparticles have been used as a potential MRI contrast agent [216, 217]. 
Magnetic resonance imaging (MRI) is a powerful non-invasive diagnostic 
technique to visualize the fine features of human body in a high spatial 
resolution [218]. MR contrast agents facilitates the achievement of clear 
images for accurate diagnosis, by exerting an influence on the longitudinal 
(T1) or transverse (T2) relaxation time of the surrounding tissue.  
Paramagnetic complexes containing gadolinium (Gd3+) or manganese (Mn2+) 
ions induce local relaxation change of the adjacent water protons and reduce 
T1, providing positive contrast (bright signal) on T1- weighted MR image. 






Similarly superparamagnetic magnetite nanoparticles, due to their strong T2 
shortening effect [219, 220], have been widely used as an ultrasensitive 
negative contrast agents for stem cell tracking and early stage cancer 
detection. Still, their clinical applications are limited due to the negative 
contrast effect and magnetic susceptibility artifacts. This is because, the dark 
areas of their negative contrast is often confused with a low-level MR signal 
arising from the nearby adjacent tissues [221, 222]. Adding to it, susceptibility 
artifacts can also occur as a result of the steep variation of local magnetic field 
around superparamagnetic magnetite nanoparticles, leading to the locally 
distorted anatomy of surrounding tissue in MR image [223]. Inorder to utilize 
the best of both the worlds, in this chapter we have discussed the synthesis of 
iron oxide- gadolinium oxide (Io-Go) nanoclusters to demonstrate their utility 
as dual contrast agents for T1- and T2-weighted MRI. Magnetic hyperthermia 
is a potential cancer treatment strategy to cure cancer by increasing the 
temperature of the tumor site upto 42C. The increase in temperature raise 
causes cell death due to apoptosis and necrosis. Iron oxide (Fe3O4) 
nanoparticles are FDA approved nanomaterials which have been widely used 
in magnetic hyperthermia.  
 
We have fabricated hydrophilic Io-Go nanoclusters by coating the same with 
polydopamine. Since our previous studies showed that thioglycolic acid 
capped Gd2O3 nanoparticles showed improved T1 relaxivity, we have used the 
same as an anchoring material for dopamine polymerization.  
 






Dopamine (DA), is the most important neurotransmitters. It can self-
polymerize to polydopamine (PDA) at alkaline pH and can spontaneously 
deposit on any surface to form a conformal layer [224]. Also, PDA is stable 
and biocompatible in vivo [225], Making it viable for biomedical applications. 
Additionally, the existence of functional groups like catechol and amine on the 
surface of PDA promotes the binding of various biomolecules [226]. In the 
recent advances, PDA has been used as a photothermal therapeutic agent for in 
vivo cancer therapy due to its strong near-infrared (NIR) absorption and high 
photothermal conversion efficiency of upto 40% [227].  
 
The Fe3O4-Gd2O3 nanoclusters are expected to induce a simultaneous positive 
and negative contrast enhancement making them useful as dual-functional 
MRI contrast agents [228]. Depending on the tissue site of interest, Fe3O4-
Gd2O3 nanoclusters can be selectively visualized by T1- or T2-weighted MRI 
in order to achieve complementary information that cannot be obtained by the 
use of just one type of contrast agent, thereby giving a more precise diagnosis. 
Our nanoclusters also serve as potential magnetic hyperthermia agents due to 
the presence of Fe3O4 nanoparticles. A schematic overview of the 
multifunctional Io-Go nanoclusters is shown in Fig. 6.1. 







Fig. 6.1: Schematic overview of the PDA coated Fe3O4-Gd2O3 nanoclusters as 




Cell viability of PDA coated Fe3O4-Gd2O3 nanoclusters  
 
The BHK cells suspended in 1xPBS were co-incubated with 100 µg/mL of 
Fe3O4-Gd2O3  nanoclusters and PDA coated Fe3O4-Gd2O3 nanoclusters for 24 
hours at 37°C. The BHK cells after incubation were run under flow 
cyclometry. Dyes NucBlue (ThermoFischer Scientific) to stain the total nuclei 
of cells, AlexaFluor (Invitrogen) to stain the apoptotic cells green and 






Propidium Iodide (PI-ThermoFischer Scientific) to stain the nucleus of dead 
cells red were used to qualitatively visualize the cells.  
  
Briefly, to 1 mm2of the BHK cells, 2 drops of NucBlue, 2.5 µL of AlexaFluor 
and 0.5 µL of PI were added along with 100 µL binding buffer and were 
incubated at room temperature for 15 minutes. The reaction was stopped by 
adding excess binding buffer and the samples were run in flow cytometry. In 
the histogram comprises of 4 quadrants. Quadrant 1 (Q1) represents cells that 
have under gone complete necrosis; Quadrant 2 (Q2) represents cells at late 
stage apoptosis, wherein the cell membrane has ruptured; Quadrant 3 (Q3) 
represents cells at early stage apoptosis; Quadrant 4 (Q4) represents live cells. 
Later the BHK cells after incubation were observed under confocal 
microscope (Olympus-FluoView, FV1000). The images were processed using 
IMARIS 8.0 software. 
 
Magnetic Hyperthermia of PDA coated Fe3O4-Gd2O3 nanoclusters 
 
The magnetic hyperthermia studies, to calculate the Specific Absorption Rate 
(SAR) were carried out by placing the 0.1mg/mL (Fe3+ concentration) Fe3O4-
Gd2O3 nanoclusters inside a copper coil generating an external AC magnetic 
field. The temperature raise of the sample with respect to the time of 
exposure of the sample to an AC magnetic field at an amplitude of 32.4 
kAm-1, frequency of 360 kHz and a magnetic field of 600 Oe was 
investigated. SAR is expressed as the heat released by the magnetic iron 






oxide nanoparticles under a magnetic field. The SAR value is calculated from 
the formula, 
 
Where, Cwat-  specific heat of the medium (distilled water), 4.18 J /g/ ºC; 
∆T/∆t- The initial slope of the time-dependent temperature curve; CFe- 
concentration of ferric ions  in the medium, 0.1mg/mL. The concentration 
of ferric ions in the samples was determined using ICP-OES analysis 
(Perkin-Elmer Dual view Optima 5300 DV ICPOES system). 
 
Magnetic hyperthermia treatment on SEM leukemia cell lines  
 
SEM leukemia cell lines which cause Acute Lymphoblastic Leukemia (ALL). 
SEM leukemia cell lines of concentration 10000 cells were used to study the 
efficiency of the Io-Go nanoclusters against leukemia cell lines. The SEM 
cells were co-incubated with 0.1 mg/mL (Fe3+ concentration) Fe3O4-Gd2O3 
nanoclusters for 3 hours at 37°C. SEM leukemia cell lines suspended in 
1xPBS was maintained as control. After the incubation period, the sample and 
the control were subjected to an applied AC magnetic field of 600 Oe 
(frequency 360 kHz), to bring a ΔT of upto 42°C-45°C. At the end of the 
magnetic hyperthermia treatment, the sample and the control were run in a 
flow cyclometry set-up. Dyes NucBlue (ThermoFischer Scientific) to stain the 
total nuclei of cells, AlexaFluor (Invitrogen) to stain the apoptotic cells green 
and Propidium Iodide (PI-ThermoFischer Scientific) to stain the nucleus of 
dead cells red were used to qualitatively visualize the cells.   







Briefly, to 1 mm2of the BHK cells, 2 drops of NucBlue, 2.5 µL of AlexaFluor 
and 0.5 µL of PI were added along with 100 µL binding buffer and were 
incubated at room temperature for 15 minutes. The reaction was stopped by 
adding excess binding buffer and the samples were run in flow cytometry. In 
the histogram comprises of 4 quadrants. Quadrant 1 (Q1) represents cells that 
have under gone complete necrosis; Quadrant 2 (Q2) represents cells at late 
stage apoptosis, wherein the cell membrane has ruptured; Quadrant 3 (Q3) 
represents cells at early stage apoptosis; Quadrant 4 (Q4) represents live cells. 
 
Relaxivity measurements of PDA coated Fe3O4-Gd2O3 nanoclusters 
 
Iron oxide- gadolinium oxide (Fe3O4-Gd2O3) nanoclusters were fabricated and 
made hydrophilic by the in-situ polymerization of dopamine. The samples 
were well dispersed and stable in water. The concentration of Gd3+ and Fe3+ 
ions in the sample were 3mM each. The samples were diluted to 5 different 
concentrations (3 mM, 1.5 mM, 0.75 mM, 0.37 mM and 0 mM). The 
longitudinal (r1) and transverse (r2) relaxivities were measured using a 7T 
Bruker ClinScan with a Siemens interface and 72 mm volume coil. T1 
measurement was done using an inversion-recovery sequence; TR/TE = 
5000/7; Average=3; flip angle = 90° and inversion-times (TIs) =31, 150, 300, 
700, 1200, 1800, 2400, 3000, 3600, 4000, 4500 and 4900 ms. T1 was 
calculated from the inversion-recovery images, by fitting for the decay curve. 
T2 measurement was performed using a multiple spin echo sequence TR = 






5000 ms; TE = 12.9; NE = 14. The sample was maintained at 36°C using a 
water bath. T2 maps were obtained along with the inline acquisition sequence 
program. The r1 and r2 values were obtained from slope of the linear fit 
between 1/T1 or 1/T2 vs concentration of contrast agent in mM. The relaxivity 
is represented as mM-1s-1 ± SD (n = 3). 
 
6.3 Results and Discussion 
 
Synthesis and hydrophilic phase transfer of Fe3O4-Gd2O3 nanoclusters 
 
Fig. 6.2(a-i) and 6.2(a-ii) shows the TEM image and SAED pattern of as-
synthesized Fe3O4 nanoparticles and Gd2O3 nanoparticles respectively. As 
seen from TEM images, the Fe3O4 nanoparticles are of 20 ±2 nm in size and 
the Gd2O3 nanoparticles are ultra-small of average size 3±1 nm. The inset 
SAED image of Fig. 6.2(a-i) shows spinel Fe3O4 corresponding to (111), 
(220), (311), (400), (422), (511), (440) and (533). The inset SAED image of 
Fig. 6.2(a-ii) shows Gd2O3 corresponding to (222), (440) and (664). Fig 2(a-
iii) shows the physical mixture of iron oxide- gadolinium oxide (Io-Go) 
nanoclusters before converting to hydrophilic phase. The SAED pattern 
corresponding to (220), (311), (400), (440) and (664) also confirms the same. 
Fig. 6.2(b) shows that the magnetization (Ms) of Iron oxide- gadolinium oxide 
(Fe3O4-Gd2O3) nanoclusters, decreases to 62 emu/g when compared to 75 
emu/g of  






Fe3O4 nanoparticles. This is due to the addition of Gd2O3 nanoparticles.  Inset 
figure shows the mild coercivity exhibited by Fe3O4, which makes it a good 
magnetic hyperthermia agent. 
 
 
Fig. 6.2: Characterization of as-synthesized Io-Go nanoclusters (a-i) TEM 
image of 20 nm Fe3O4 nanoparticles. Inset image is the SAED pattern (a-ii) 
TEM image of 3 nm Gd2O3 nanoparticles. Inset image is the SAED pattern (a-
iii) TEM image of Io-Go nanoclusters. Inset image is the SAED pattern (b) 
saturation magnetization (Ms) of Io-Go nanoclusters. Inset image shows the 
coercivity of 20 nm Fe3O4 nanoparticles. 
 






The as-synthesized nanoclusters were made hydrophilic by ligand exchange 
using thioglycolic acid. The carboxy group of thioglycolic acid capped Fe3O4-
Gd2O3 nanoclusters were later incubated in dopamine for insitu 
polymerization. Fig. 6.3(a) shows that the Gd2O3 nanoparticles and Fe3O4 
nanoparticles were clustered together within PDA. Gd2O3 nanoparticles are 
well decorated over the Fe3O4 nanoparticles as seen from the figure. Fig. 
6.3(b) shows the SAED pattern corresponding to (220), (311), (400), (440) 
and (664) of the PDA coated Fe3O4-Gd2O3 nanoclusters. Fig. 6.3(c) shows the 
EDAX spectrum of Io-Go nanoclusters. It shows the weight % of Fe-Gd is 
almost 1:1 (53%: 47%). Inset table gives the quantitative measurement of the 
same. The PDA coated Fe3O4-Gd2O3 nanoclusters were well-dispersed and 
were stable in water. This is evident from Fig. 6.3(d). The average 
hydrodynamic radius of the PDA coated Fe3O4-Gd2O3 nanoclusters is 40±2 
nm. Fig. 6.4(e) confirms the dopamine polymerization on Fe3O4-Gd2O3 
nanoclusters. Dopamine has no absorbance peak between 300-900 nm. 
Whereas polydopamine coated Fe3O4-Gd2O3 nanoclusters show a 
characteristic peak around 400-500 nm, confirming the in-situ polymerization 
of dopamine on the Io-Go nanoclusters. 







Fig. 6.3: Hydrophilic phase transfer of Fe3O4 nanoparticle (a) TEM image of 
PDA coated Fe3O4-Gd2O3 nanoclusters  shows that the Gd2O3 nanoparticles 
are decorated over Fe3O4 nanoparticles and coated with PDA (b) SAED 
pattern of Fe3O4-Gd2O3 nanoclusters (c) EDAX spectrum of Fe3O4-Gd2O3 
nanoclusters (d) Average hydrodynamic radius of  PDA coated Fe3O4-Gd2O3 
nanoclusters (e) UV-Vis spectrum of PDA coated Fe3O4-Gd2O3 nanoclusters. 
 
 
Cell viability of PDA coated Io-Go nanoclusters 
 
The cell viability of Fe3O4-Gd2O3 nanoclusters is 97% when compared to 98% 
of PDA coated Fe3O4-Gd2O3 nanoclusters as seen from the Fig. 6.4(a) and 
6.4(b) respectively. From Fig. 6.4(b) it is evident that there is fewer cells in 
early stage apoptosis (Q3) when compared to that of Fig. 6.4(a). This shows 






that PDA coated Fe3O4-Gd2O3 nanoclusters exhibit less or no cytotoxicity to 
healthy BHK cells. Therefore PDA coating render biocompatibility to the Io-
Go nanoclusters and hence make them a promising candidates for magnetic 
hyperthermia and MRI applications. 
 
Fig. 6.4: Cell viability studies of (a) Io-Go nanoclusters-97 % (b) PDA coated 
Fe3O4-Gd2O3 nanoclusters- 98 %.  
 
 
Magnetic hyperthermia of PDA coated Fe3O4-Gd2O3 nanoclusters 
 
Fig. 6.5 shows the comparison of temperature raise (∆T) curves due to the 
PDA coated Fe3O4 nanoparticles and PDA coated Fe3O4-Gd2O3 nanoclusters. 
The decoration with Gd2O3 nanoparticles decreases the temperature raise (∆T) 
to 4.2°C, when compared to 7°C of PDA coated Fe3O4 nanoparticles.  As seen 
from the inset figure, the SAR value of Fe3O4-Gd2O3 nanoclusters is 785 W/g 
also slightly lower than that of PDA coated Fe3O4 nanoparticles, which is 920 
W/g. This is decrease in SAR value is expected and is well within the 
statistical  






error range. Therefore it does not much affect the heating efficiency of PDA 
coated Fe3O4-Gd2O3 nanoclusters.  The SAR value of PDA coated Fe3O4-




Fig. 6.5: Temperature raise comparison between PDA coated Fe3O4 
nanoparticles and PDA coated Fe3O4-Gd2O3 nanoclusters. Inset figure is the 
SAR value comparison of the same. 
 
 
Fig. 6.6(a) shows the histogram of untreated SEM leukemia cell lines. It is 
obvious from the histograms that the application of AC magnetic field alone 






without Fe3O4-Gd2O3 nanoclusters, causes almost no damage (97.8 %) to the 
tumor cell line. Whereas the application of 600 Oe magnetic field along with 
0.1 mg/mL (Fe3+ concentration) of Io-Go nanoclusters raises the temperature 
upto 45°C causing tumor cell death leading to 74 % as shown in Fig. 6.6(b). It 
is very clear from Fig. 6.6(b) that there are more cells entering late stage 
apoptosis (Q2) and complete necrosis (Q1). Thus the fabricated Fe3O4-Gd2O3 
nanoclusters are very good magnetic hyperthermia agents. 
 
 
Fig. 6.6: Magnetic hyperthermia treatment on SEM leukemia cell line using 
PDA coated Fe3O4-Gd2O3 nanoclusters a) Cell line before treatment- 97.8% 
viability b) Cell line after treatment- 74% viability. 
 
 
Relaxivity studies of PDA coated Fe3O4-Gd2O3 nanoclusters 
 
To be an effective T1 contrast agent, the nanoparticles are expected to have 
hydrophilic coating surface, to ensure that a large quantity of Gd2O3 
nanoparticles directly interact with the surrounding protons. Our PDA coated 






Fe3O4-Gd2O3 nanoclusters have Gd2O3 nanoparticles decorated over the Fe3O4 
nanoparticles and hence are readily available for proton interaction. As 
expected,  Fig. 6.7 PDA Fe3O4-Gd2O3 nanoclusters show a r1 value of 5.8 
mM-1s-1 and r2 value of 6.7 mM-1s-1. Moreover the polar groups in each 
nanocluster allows the water molecules to pass through the coating layer and 
interact with Gd2O3 nanoparticles and Fe3O4 nanoparticles which could the 
reduced T1 and T2 relaxation time. The inset phantom images of PDA coated 
Fe3O4-Gd2O3 nanoclusters at different concentrations clearly demonstrated 
their contrast difference as dual contrast agents.  
 
 
Fig. 6.7: Plots of 1/T1 and 1/T2 as a function of Gd and Fe concentration. 
Inset images shows the corresponding phantom images of Fe3O4-Gd2O3 
nanoclusters corresponding to Gd+Fe concentration in mM. 
 









We have successfully fabricated PDA coated iron oxide- gadolinium oxide 
(Fe3O4-Gd2O3) nanoclusters which can be used as a multifunctional platform 
for magnetic hyperthermia and dual mode MRI imaging. This gives the 
nanoclusters a theranostic value. The PDA coated Fe3O4-Gd2O3nanoclusters 
show effective magnetic hyperthermia properties (of SAR value 920 W/g) 
without compromising on the tissue viability. It also shows significant tumor 
necrosis of upto 74%, making it a very good magnetic hyperthermia agent. 
Since the tissue viability of PDA coated Fe3O4-Gd2O3 nanoclusters is 
significant, it also is a safe biocompatible agent under the field used for MRI. 
The T1 and T2 relaxivity measurements of give r1 and r2 values of 5.8 mM-1s-
1 and 6.7 mM-1s-1 respectively making our PDA coated Fe3O4-Gd2O3 
nanoclusters, a potential dual contrast agent for MRI applications. Though the 
scope of PDA coated Fe3O4-Gd2O3 nanoclusters as photothermal agents, is 
beyond the scope of this chapter, exploration of the same is a potential future 
application of the same.  
 


































This thesis discusses about the fabrication of magnetic metal oxide (Fe3O4, 
Gd2O3) nanoparticles and their application in cancer theranostics, viz, 
magnetic hyperthermia and magnetic resonance imaging. We have also 
discussed the influence of physiology on magnetic hyperthermia. 
 
1) In chapter 2 we have discussed the synthesis of various magnetic metal 
oxides nanoparticles by thermal decomposition method. Thermal 
decomposition method yields uniform and monodisperse particles. The as-
synthesized, oleic acid capped, hydrophobic nanoparticles were converted 
to hydrophilic and biocompatible phase by various methods- surface 
modification (CTAB, PEI), ligand exchange (APTMS, TA, PVP) in-situ 
polymerization (dopamine) and bioconjugation (BSA). This chapter also 
explores the characterization techniques used to characterize the particles 
at various stages of experiments. 
 
2) In chapter 3 we have discussed the fabrication of hydrophilic Fe3O4 
nanoparticles of different size, shape, composition and surface 
modification. Among the 10 nm superparamagnetic iron oxide 
nanoparticles (SPIONs) and 30 nm ferrimagnetic iron oxide nanoparticles 
(FIONs), FIONs have higher magnetic saturation of 87 emu/g and hence 
show higher SAR value of 1700 W/g, irrespective of the surface modifying 
agent used. APTMS capping showed better stability when compared to  





CTAB or PEI coating. Hence APTMS was further used in our hydrophilic 
phase transfer experiments. Also 30 nm Fe3O4 nanoparticles also have 
optimum size for biological applications.  Both 10 nm and 30 nm Fe3O4 
nanoparticles show very high cell viability of upto 99%. We had fabricated 
hydrophilic nanospheres, nanohexagons and nanotetragons of 20 nm size. 
Nanotetragons were found to show polydispersity and also exhibited high 
magnetic hyperthermia efficiency of 1800 W/g. Composition of the Fe3O4 
nanoparticles were modified by doping with divalent ions like cobalt and 
nickel. CoFe2O4 nanoparticles of size 15 nm show higher coercivity and 
hence higher SAR value of 885 W/g when compared to 15 nm Fe3O4 
nanoparticles and 150 nm NiFe2O4 nanoparticles. This chapter gives the 
preliminary insights into fabrication of different types of Fe3O4 
nanoparticles for magnetic hyperthermia applications. Hydrophilic phase 
transfer improves the colloidal stability of nanoparticles. But improving 
the biocompatibility enhances the potential chance of the nanoparticles for 
biomedical applications. Therefore in the later section of chapter 3, we 
have discussed the fabrication of albumin conjugated 30 nm Fe3O4 
nanoparticles. Bovine Serum Albumin (BSA) conjugation has found to 
enhance both the biocompatibility and the heating efficiency of the Fe3O4 
nanoparticles. We have conjugated BSA over surface modified Fe3O4 
nanoparticles by physical adsorption method using CTAB and covalent 
amide bond formation by APTMS. Albumin is the most abundant protein 
present in blood plasma and hence it offers better stealth characteristics. 
This is proved by haemolytic studies and cell viability studies using BHK 
cell lines. The cell viability is upto 99.5% after BSA conjugation. BSA 




conjugation also renders better stability and prevents aggregation of Fe3O4 
nanoparticles in water, thus enhancing the heating efficiency upto 2300 
W/g. Magnetic hyperthermia treatment of BSA conjugated FIONs show 
better efficiency on liver tissue excised from 5 weeks old male Witstar rats 
when compared to the non-conjugated Fe3O4 nanoparticle. Thus we 
propose a single combinatorial approach for improved biocompatibility 
and enhanced magnetic hyperthermia performance. 
 
3) Various physical and chemical parameters like size, shape, anisotropy, 
composition, applied magnetic field etc., influence the magnetic 
hyperthermia efficiency of magnetic nanoparticles. In chapter 4 we have 
attempted to explore the basic properties of Fe3O4 nanoparticles once 
inside a biosytem. While physiological ions enhance the heating efficiency 
of 10 nm SPIONs due to their motility, the physiological proteins and cells 
present in blood plasma, restrict the mobility of the ions, thereby retarding 
the heating efficiency of the SPIONs. Thus acting as biosafety agents. 
Therefore the adverse effects of magnetic nanoparticles on a biosystem is 
under check. We have also found that AC magnetic field at therapeutic 
range does not cause damage to the tissue, thus confirming that magnetic 
hyperthermia effect is brought about by SPIONs under the influence AC 
magnetic field. This study throws basic insights into the fundamentals of 
magnetic hyperthemia inside physiology. This study throws light into the 
basic scientific explanation behind the tissue viability under the AC 
magnetic field, despite the increase in temperature. Thus it gives future 




directions for the fabrication of better magnetic nanoparticles for effective 
magnetic hyperthermia.  
 
4) Chapter 5 explores the application of Gd2O3 nanoparticles as potential T1 
contrast agents for MRI diagnostic applications. We have compared the 
relaxivity values between TA capped Gd2O3 nanoparticles and BSA 
conjugated Gd2O3 nanoparticles. While BSA conjugated Gd2O3 
nanoparticles show a r1 of 2.8 mM-1s-1 when compared to 3.3 mM-1s-1 they 
show a very good cell viability of upto 99.6% and 1.2% haemolysis. The 
later section of this chapter discusses the coating of inorganic, in-situ 
photodegraded PVP coating over Gd2O3 nanoparticles. This technique 
gave better contrast of relaxivity value 12.3 mM-1s-1 owing to the 
availability of gadolinium ions for relaxation. The cell viability is also 
extremely good, as much as 99 %. 
 
5) Chapter 6 discusses the fabrication of iron oxide-gadolinium oxide (Io-Go) 
nanoclusters which can be used as a multifunctional platform for magnetic 
hyperthermia and dual mode MRI imaging. The PDA coated Io-Go 
nanoclusters show effective magnetic hyperthermia of upto 920 W/g 
without compromising on the cell viability (98%). It also shows significant 
tumor necrosis of SEM leukemia cell lines upto 74%, making it a very 
good magnetic hyperthermia agent. PDA coated Io-Go nanoclusters are 
also found to act as good T1 and T2 dual contrast agents showing a good 
r1 value of 5.8 mM-1s-1 and r2 value of 6.7 mM-1s-1 for MRI applications. 
 






7.2 Future works 
 
1) In chapter 3, we have synthesized monodisperse 10 nm and 30 nm Fe3O4 
nanoparticles. In future Fe3O4 nanoparticles of more size ranges can be 
fabricated to study the trend of the effect of size on SAR value of Fe3O4 
nanoparticles. Also more shapes with uniform size can be fabricated. The 
physics behind the magnetic properties can be further explored. Simulation 
studies to support the experimental results can be done. Also the results in 
the last section of chapter 3 prove that conjugation of physiological 
proteins improve the stealth and heating properties of Fe3O4 nanoparticles. 
Though we have studied the cell viability and magnetic hyperthermia of 
the performance of the BSA conjugated Fe3O4 nanoparticles in vitro, 
exploring the blood circulation time of the particles and magnetic 
hyperthermia performance of the particles in vivo can be a next big step in 
confirming the efficacy of the single combinatorial approach. 
 
2) Exploring the in vivo magnetic hyperthermia performance of BSA 
conjugated Gd2O3 nanoparticles discussed in chapter 5, which have proven 
to show good biocompatibility and relaxivity values is a future work. Since 
in-situ PVP coating has shown very good relaxivity values, the in vivo 
MRI properties have to be better understood. 
 
 





3) In chapter 6 we have discussed the fabrication of PDA coated Io-Go 
nanoclusters. The nanoclusters have proven to have good magnetic 
hyperthermia and dual contrast properties, in vitro. But exploring the MRI 
application of the Io-Go nanoclusters in vivo is a much needed extension 
of the work. The in vivo magnetic hyperthermia performance for tumor 
retardation can also be studied in the future, to develop the same as a 
complete multifunctional platform for cancer therapy, as in magnetic 
hyperthermia and diagnostics a sin MR imaging, thus making Io-Go 
nanoclusters as potential theranostics agents. Though the photothermal 
therapy of due to Polydopamine is beyond the scope of this thesis, the 
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